NeoGenomics, Inc(NASDAQ:NEO) 
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates in two segments, Clinical Services and Pharma Services. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceuti...
Website: http://www.neogenomics.com
Founded: 2002
Full Time Employees: 1,700
CEO: Douglas M. Van Oort
Sector: Healthcare
Industry: Diagnostics & Research
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-05-13 | 2008-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net revenue | 186,672,000 | 190,170,000 | 187,797,000 | 181,330,000 | 168,035,000 | 27,279,000 | 25,126,000 | 24,370,000 | 23,026,000 | 24,999,000 | 23,217,000 | 20,670,000 | 18,182,000 | 18,323,000 | 16,884,000 | 15,603,000 | 15,657,000 | 14,894,000 | 14,202,000 | 15,611,000 | 15,160,000 | 12,893,000 | 11,320,000 | 10,466,000 | 8,805,000 | 8,708 | 8,490 | 8,418,000 | 7,799,409 | 7,296,800 | 7,459,326 | 6,913,520 | 14,094,959 | 4,881,402 | 4,162,762 | 4,162,762 | ||||||||||||||||||||||||||||||||||||||
cost of revenue | 105,808,000 | 106,827,000 | 107,351,000 | 104,072,000 | 94,789,000 | 94,743,000 | 92,944,000 | 92,008,000 | 90,771,000 | 87,964,000 | 89,643,000 | 87,026,000 | 82,406,000 | 81,880,000 | 79,889,000 | 81,126,000 | 78,937,000 | 80,475,000 | 74,101,000 | 68,734,000 | 73,959,000 | 68,544,000 | 71,379,000 | 58,971,000 | 59,661,000 | 56,945,000 | 53,840,000 | 52,747,000 | 48,462,000 | 39,365,000 | 36,775,000 | 37,216,000 | 36,120,000 | 34,661,000 | 34,242,000 | 34,912,000 | 34,480,000 | 33,233,000 | 33,416,000 | 34,524,000 | 32,531,000 | 15,051,000 | 13,955,000 | 13,557,000 | 13,482,000 | 13,529,000 | 12,923,000 | 10,431,000 | 9,473,000 | 9,160,000 | 8,713,000 | 8,446,000 | 8,411,000 | 8,460,000 | 8,310,000 | 8,244,000 | 8,016,000 | 7,060,000 | 6,246,000 | 5,810,000 | 4,940,000 | 4,818 | 4,575 | 4,344,000 | 4,107,461 | 3,672,289 | 3,384,035 | 3,090,442 | 6,577,549 | 2,183,758 | 1,858,474 | 1,858,474 | ||
gross profit | 80,864,000 | 57,737,500 | 80,446,000 | 77,258,000 | 73,246,000 | 77,257,000 | 74,880,000 | 72,494,000 | 65,469,000 | 67,588,000 | 62,311,000 | 59,891,000 | 54,814,000 | 56,825,000 | 48,893,000 | 43,946,000 | 38,232,000 | 45,257,000 | 47,239,000 | 52,990,000 | 41,574,000 | 57,453,000 | 54,065,000 | 28,006,000 | 46,369,000 | 49,923,000 | 50,832,000 | 48,966,000 | 47,115,000 | 22,538,750 | 32,321,000 | 30,530,000 | 27,303,000 | 21,796,000 | 28,810,000 | 31,178,000 | 7,311,000 | 10,294,000 | 10,239,000 | 5,643,500 | 8,171,000 | 7,157,000 | 5,100,500 | 5,892,000 | 7,367,000 | 3,398,750 | 5,074,000 | 4,656,000 | 3,890 | 3,915 | 2,880,719.75 | 3,624,511 | 4,075,291 | 3,823,078 | 7,517,410 | 2,697,644 | 2,304,288 | 2,304,288 | ||||||||||||||||
yoy | 10.40% | -25.27% | 7.43% | 6.57% | 11.88% | 14.31% | 20.17% | 21.04% | 19.44% | 18.94% | 27.44% | 36.28% | 43.37% | 25.56% | 3.50% | -17.07% | -8.04% | -21.23% | -12.63% | 89.21% | -10.34% | 15.08% | 6.36% | -42.81% | -1.58% | 121.50% | 57.27% | 60.39% | 72.56% | 3.41% | 12.19% | -2.08% | 29.55% | 25.98% | 43.06% | 10.65% | 38.68% | -2.85% | 50.07% | 16.12% | 58.23% | 130337.02% | 118827.20% | -99.89% | -99.90% | -51.79% | 51.07% | 65.91% | ||||||||||||||||||||||||||
qoq | 40.05% | -28.23% | 4.13% | 5.48% | -5.19% | 3.17% | 3.29% | 10.73% | -3.14% | 8.47% | 4.04% | 9.26% | -3.54% | 16.22% | 11.26% | 14.95% | -15.52% | -4.20% | -10.85% | 27.46% | -27.64% | 6.27% | 93.05% | -39.60% | -7.12% | -1.79% | 3.81% | 3.93% | 109.04% | -30.27% | 5.87% | 11.82% | 25.27% | -24.35% | -7.60% | -28.98% | 0.54% | -30.93% | 14.17% | -13.43% | -20.02% | -33.02% | 8.98% | -0.64% | -20.52% | -11.06% | 6.60% | 178.67% | 17.07% | 0.00% | ||||||||||||||||||||||||
gross margin % | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | 63.25% | 44.62% | 44.07% | 41.90% | 43.45% | 41.01% | 40.77% | 39.95% | 40.97% | 37.97% | 35.14% | 32.63% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | Infinity% | Infinity% | Infinity% | NaN% | Infinity% | Infinity% | Infinity% | NaN% | Infinity% | Infinity% | Infinity% | NaN% | Infinity% | Infinity% | Infinity% | NaN% | NaN% | Infinity% | Infinity% | NaN% | Infinity% | Infinity% | Infinity% | Infinity% | NaN% | Infinity% | Infinity% | Infinity% | Infinity% |
operating expenses: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
general and administrative | 65,741,000 | 63,509,000 | 69,874,000 | 71,747,000 | 68,207,000 | 63,643,000 | 66,969,000 | 63,328,000 | 65,797,000 | 59,758,000 | 61,486,000 | 60,308,000 | 61,549,000 | 54,875,000 | 64,282,000 | 57,951,000 | 66,248,000 | 62,394,000 | 63,839,000 | 54,638,000 | 40,476,000 | 36,709,000 | 36,128,000 | 34,613,000 | 36,344,000 | 33,220,000 | 33,054,000 | 29,577,000 | 32,142,000 | 25,716,000 | 21,055,000 | 20,983,000 | 17,067,000 | 22,012,000 | 23,267,000 | 22,675,000 | 20,801,000 | 19,972,000 | 19,025,000 | 18,779,000 | 18,005,000 | 12,595,000 | 7,438,000 | 7,075,000 | 6,522,000 | 6,513,000 | 6,370,000 | 5,870,000 | 5,054,000 | 4,824,000 | 4,335,000 | 4,064,000 | 4,175,000 | 4,098,000 | 3,929,000 | 4,066,000 | 3,750,000 | 3,657,000 | 3,307,000 | 3,086,000 | 2,823,000 | 2,919 | 2,769 | 2,902,000 | 3,043,618 | 2,457,978 | 3,675,084 | 7,706,284 | 2,556,121 | 2,514,555 | 2,514,555 | |||
research and development | 9,534,000 | 9,179,000 | 8,694,000 | 9,023,000 | 10,181,000 | 7,969,000 | 7,684,000 | 7,886,000 | 7,620,000 | 7,127,000 | 5,285,000 | 7,502,000 | 7,395,000 | 6,675,000 | 7,312,000 | 8,626,000 | 7,713,000 | 8,513,000 | 7,409,000 | 3,495,000 | 2,456,000 | 2,100,000 | 1,964,000 | 2,105,000 | 2,060,000 | 2,080,000 | 2,611,000 | 2,587,000 | 1,209,000 | 526,000 | 446,000 | 1,073,000 | 956,000 | 556,000 | 1,270,000 | 947,000 | 862,000 | 930,000 | 967,000 | 1,306,000 | 1,446,000 | 1,856,000 | 871,000 | 803,000 | 669,000 | 414,000 | 1,014,000 | 633,000 | 628,000 | 649,000 | 340,000 | 616,000 | 835,000 | 448,000 | 808,000 | 528,000 | 497,000 | |||||||||||||||||
sales and marketing | 23,830,000 | 23,443,000 | 21,806,000 | 24,075,000 | 22,683,000 | 22,339,000 | 20,415,000 | 21,677,000 | 20,221,000 | 18,072,000 | 17,610,000 | 18,901,000 | 16,259,000 | 17,142,000 | 16,809,000 | 17,071,000 | 16,299,000 | 15,917,000 | 15,704,000 | 17,224,000 | 13,749,000 | 13,105,000 | 11,304,000 | 10,195,000 | 13,258,000 | 12,302,000 | 11,508,000 | 12,324,000 | 11,216,000 | 8,047,000 | 6,900,000 | 7,680,000 | 6,775,000 | 6,077,000 | 6,577,000 | 6,242,000 | 5,648,000 | 5,826,000 | 5,958,000 | 6,327,000 | 5,800,000 | 2,993,000 | 2,748,000 | 2,907,000 | 2,914,000 | 3,224,000 | 2,983,000 | 3,158,000 | 2,633,000 | 2,487,000 | 2,336,000 | 1,972,000 | 1,931,000 | 1,692,000 | 1,839,000 | 1,934,000 | 2,036,000 | 1,801,000 | 1,725,000 | 1,684,000 | 1,753,000 | 1,983 | 1,943 | 1,763,000 | 2,035,926 | 1,792,955 | ||||||||
total operating expenses | 99,105,000 | 96,757,000 | 107,460,000 | 124,886,000 | 101,071,000 | 95,658,000 | 96,077,000 | 94,435,000 | 96,036,000 | 86,162,000 | 86,506,000 | 89,785,000 | 89,887,000 | 83,208,000 | 88,403,000 | 83,648,000 | 90,260,000 | 86,824,000 | 86,952,000 | 75,357,000 | 56,681,000 | 51,914,000 | 49,396,000 | 46,913,000 | 51,662,000 | 47,602,000 | 47,173,000 | 44,488,000 | 44,567,000 | 34,289,000 | 28,401,000 | 29,736,000 | 24,798,000 | 28,645,000 | 32,172,000 | 29,864,000 | 27,311,000 | 30,192,000 | 25,950,000 | 26,412,000 | 25,251,000 | 17,444,000 | 11,057,000 | 10,785,000 | 10,105,000 | 10,151,000 | 10,367,000 | 9,661,000 | 8,315,000 | 7,960,000 | 7,011,000 | 6,652,000 | 6,941,000 | 6,238,000 | 6,576,000 | 6,528,000 | 6,283,000 | 3,594,750 | 5,032,000 | 4,770,000 | 4,576,000 | 4,902 | 4,712 | 4,665,000 | 4,705,393 | 4,379,816 | 4,067,231 | 3,789,900 | 7,905,620 | 2,625,367 | 2,569,651 | 2,569,651 | ||
income from operations | -18,241,000 | -13,414,000 | -27,014,000 | -47,628,000 | -27,825,000 | -18,401,000 | -21,197,000 | -21,941,000 | -30,567,000 | -18,574,000 | -24,195,000 | -29,894,000 | -35,073,000 | -26,383,000 | -39,510,000 | -39,702,000 | -52,028,000 | -41,567,000 | -39,713,000 | -22,367,000 | -15,107,000 | 5,539,000 | 4,669,000 | -18,907,000 | -5,293,000 | 2,321,000 | 3,659,000 | 4,478,000 | 2,548,000 | 2,821,000 | 3,920,000 | 794,000 | 2,505,000 | 4,487,000 | -3,362,000 | 1,314,000 | -115,000 | -2,935,000 | 1,395,000 | 2,193,000 | 1,922,000 | -5,216,000 | 114,000 | 28,000 | -561,000 | 1,319,000 | -73,000 | 578,000 | 394,000 | 1,203,000 | 1,160,000 | 505,000 | 305,000 | 196,000 | -684,000 | 839,000 | 861,000 | 375,000 | 42,000 | -114,000 | -711,000 | -1,012 | ||||||||||||
yoy | -34.44% | -27.10% | 27.44% | 117.07% | -8.97% | -0.93% | -12.39% | -26.60% | -12.85% | -29.60% | -38.76% | -24.70% | -32.59% | -36.53% | -0.51% | 77.50% | 244.40% | -850.44% | -950.57% | 18.30% | 185.41% | 138.65% | 27.60% | -522.22% | -307.73% | -17.72% | -6.66% | 463.98% | 1.72% | -37.13% | -216.60% | -39.57% | -2278.26% | -252.88% | -341.00% | -40.08% | -105.98% | -43.73% | 1123.68% | 7732.14% | -442.60% | -495.45% | -256.16% | -95.16% | -242.39% | 9.64% | -106.29% | 14.46% | 29.18% | 513.78% | -269.59% | -39.81% | -64.58% | -47.73% | -1728.57% | -835.96% | -221.10% | -4250.20% | ||||||||||||||||
qoq | 35.98% | -50.34% | -43.28% | 71.17% | 51.21% | -13.19% | -3.39% | -28.22% | 64.57% | -23.23% | -19.06% | -14.77% | 32.94% | -33.22% | -0.48% | -23.69% | 25.17% | 4.67% | 77.55% | 48.06% | -372.74% | 18.63% | -124.69% | 257.21% | -328.05% | -36.57% | -18.29% | 75.75% | -9.68% | -28.04% | 393.70% | -68.30% | -44.17% | -233.46% | -355.86% | -1242.61% | -96.08% | -310.39% | -36.39% | 14.10% | -136.85% | -4675.44% | 307.14% | -104.99% | -142.53% | -1906.85% | -112.63% | 46.70% | -67.25% | 3.71% | 129.70% | 65.57% | 55.61% | -128.65% | -181.53% | -2.56% | 129.60% | 792.86% | -136.84% | -83.97% | ||||||||||||||
operating margin % | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -15.07% | -12.63% | -13.34% | -19.56% | -11.94% | -15.92% | -20.35% | -25.56% | -19.02% | -30.68% | -31.74% | -44.40% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | Infinity% | Infinity% | -Infinity% | -Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | -Infinity% | Infinity% | -Infinity% | -Infinity% | Infinity% | Infinity% | Infinity% | -Infinity% | Infinity% | Infinity% | -Infinity% | Infinity% | -Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | -Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | -Infinity% | -Infinity% | NaN% | -Infinity% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% |
interest income | -1,273,000 | -1,523,000 | -1,563,000 | -2,263,000 | -3,721,000 | -4,328,000 | -4,673,000 | -4,592,000 | -4,834,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest expense | 598,000 | 599,000 | 603,000 | 933,000 | 1,618,000 | 1,624,000 | 1,642,000 | 1,666,000 | 1,685,000 | 13,738,000 | -2,840,000 | -2,524,000 | -1,467,000 | -860,000 | 139,000 | 926,000 | 1,301,000 | 1,707,000 | 1,296,000 | 902,000 | 1,177,000 | 2,194,000 | 2,458,000 | 1,548,000 | 819,000 | 380,000 | 203,000 | 1,304,000 | 1,826,000 | 1,191,500 | 1,873,000 | 1,407,000 | 1,486,000 | 1,043,250 | 1,398,000 | 1,411,000 | 1,364,000 | 1,127,250 | 1,468,000 | 1,448,000 | 1,593,000 | -906,542 | 128,883 | 130,452 | 114,816 | 199,336 | 69,246 | 55,096 | 55,096 | |||||||||||||||||||||||||
other expense | 12,000 | -84,000 | 335,000 | -482,000 | -65,000 | 431,000 | -317,000 | 2,000 | 263,000 | -124,000 | 96,000 | -730,000 | 114,000 | 1,000 | -25,000 | 405,000 | 4,854,000 | -4,222,000 | -11,000 | -7,405,000 | -223,000 | -494,000 | -35,000 | -10,000 | 5,169,000 | -45,000 | -30,000 | 124,000 | ||||||||||||||||||||||||||||||||||||||||||||||
loss before taxes | -17,578,000 | -12,406,000 | -26,389,000 | -45,816,000 | -25,657,000 | -16,128,000 | -17,849,000 | -19,017,000 | -27,681,000 | -15,286,000 | -21,451,000 | -26,640,000 | -33,720,000 | -53,161,000 | -21,138,000 | -5,889,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax expense | -472,000 | 70,500 | 740,000 | 266,000 | -3,753,000 | 976,000 | -7,850,000 | -335,000 | -11,132,000 | 1,089,000 | -3,861,000 | 1,348,000 | 175,000 | -2,023,000 | 1,049,000 | 54,000 | -357,000 | 438,000 | -134,750 | 340,000 | -54,000 | -825,000 | -2,201,000 | -6,000 | 332,000 | 174,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
net income | -17,106,000 | -9,881,000 | -27,129,000 | -45,092,000 | -25,923,000 | -15,324,000 | -17,699,000 | -18,642,000 | -27,061,000 | -14,326,000 | -18,516,000 | -24,331,000 | -30,795,000 | -22,687,000 | -36,852,000 | -35,303,000 | -49,408,000 | -41,759,000 | -20,348,000 | 75,873,000 | -22,114,000 | 15,417,000 | 2,557,000 | -6,824,000 | -6,978,000 | 6,296,000 | 2,143,000 | 1,991,000 | -2,424,000 | 353,000 | 2,023,000 | -380,000 | 644,000 | -1,449,250 | -5,100,000 | -43,000 | -654,000 | -6,223,000 | -67,000 | 413,000 | 155,000 | -1,473,000 | -125,000 | -176,000 | -761,000 | 1,047,000 | -291,000 | 274,000 | 102,000 | 857,000 | 900,000 | 273,000 | 3,000 | -113,000 | -975,000 | 551,000 | 603,000 | 152,000 | -143,000 | -293,000 | -893,000 | -1,198 | -978 | -750,000 | -1,528,745 | -755,305 | 8,060 | 33,178 | -388,210 | 72,277 | -265,363 | -265,363 | ||
yoy | -34.01% | -35.52% | 53.28% | 141.88% | -4.21% | 6.97% | -4.41% | -23.38% | -12.13% | -36.85% | -49.76% | -31.08% | -37.67% | -45.67% | 81.11% | -146.53% | 123.42% | -370.86% | -895.78% | -1211.86% | 216.91% | 144.87% | 19.32% | -442.74% | 187.87% | 1683.57% | 5.93% | -623.95% | -476.40% | -124.36% | -139.67% | 783.72% | -198.47% | -76.71% | 7511.94% | -110.41% | -521.94% | 322.47% | -46.40% | -334.66% | -120.37% | -240.69% | -57.04% | -164.23% | -846.08% | 22.17% | -132.33% | 0.37% | 3300.00% | -858.41% | -192.31% | -50.45% | -99.50% | -174.34% | 581.82% | -288.05% | -167.53% | 11836.56% | 29859.10% | 19.07% | -99.84% | -112.13% | -2360.53% | 94.56% | -88.85% | -112.50% | ||||||||
qoq | 73.12% | -63.58% | -39.84% | 73.95% | 69.17% | -13.42% | -5.06% | -31.11% | 88.89% | -22.63% | -23.90% | -20.99% | 35.74% | -38.44% | 4.39% | -28.55% | 18.32% | 105.22% | -126.82% | -443.10% | -243.44% | 502.93% | -137.47% | -2.21% | -210.83% | 193.79% | 7.63% | -182.14% | -786.69% | -82.55% | -632.37% | -159.01% | -144.44% | -71.58% | 11760.47% | -93.43% | -89.49% | 9188.06% | -116.22% | 166.45% | -110.52% | 1078.40% | -28.98% | -76.87% | -172.68% | -459.79% | -206.20% | 168.63% | -88.10% | -4.78% | 229.67% | 9000.00% | -102.65% | -88.41% | -276.95% | -8.62% | 296.71% | -206.29% | -51.19% | -67.19% | 22.49% | -99.87% | -50.94% | 102.40% | -9471.03% | -75.71% | -637.11% | -127.24% | 0.00% | |||||
net income margin % | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -12.55% | -10.55% | -11.33% | -17.32% | -9.21% | -12.19% | -16.56% | -22.44% | -16.36% | -28.62% | -28.23% | -42.17% | -Infinity% | -Infinity% | Infinity% | -Infinity% | Infinity% | Infinity% | -Infinity% | -Infinity% | Infinity% | Infinity% | Infinity% | -Infinity% | Infinity% | Infinity% | -Infinity% | Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | Infinity% | Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | Infinity% | -Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | -Infinity% | -Infinity% | Infinity% | Infinity% | Infinity% | -Infinity% | -Infinity% | -Infinity% | NaN% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | Infinity% | Infinity% | NaN% | -Infinity% | Infinity% | -Infinity% | -Infinity% |
net income per share | -0.005 | -0.01 | -0.01 | -0.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | -0.13 | -0.07 | -0.21 | -0.35 | -0.2 | -0.12 | -0.14 | -0.15 | -0.21 | -0.11 | -0.15 | -0.19 | -0.25 | -0.18 | -0.3 | -0.28 | -0.4 | -0.35 | -0.17 | 0.64 | -0.19 | 0.14 | 0.02 | -0.06 | -0.07 | -0.03 | -0.043 | -0.1 | -0.03 | -0.04 | -0.053 | -0.07 | -0.07 | -0.07 | ||||||||||||||||||||||||||||||||||||||||
diluted | -0.13 | -0.07 | -0.21 | -0.35 | -0.2 | -0.12 | -0.14 | -0.15 | -0.21 | -0.11 | -0.15 | -0.19 | -0.25 | -0.18 | -0.3 | -0.28 | -0.4 | -0.35 | -0.17 | 0.59 | -0.19 | 0.14 | 0.04 | -0.06 | -0.07 | -0.03 | -0.043 | -0.1 | -0.03 | -0.04 | -0.053 | -0.07 | -0.07 | -0.07 | ||||||||||||||||||||||||||||||||||||||||
weighted-average common shares outstanding | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 129,166 | 128,101 | 128,415 | 127,949 | 127,376 | 126,658 | 126,953 | 126,405 | 126,111 | 125,502 | 125,687 | 125,356 | 125,026 | 124,217 | 124,425 | 124,068 | 123,630 | 119,962 | 122,559 | 118,287 | 116,199 | 108,579 | 110,461 | 107,887 | 104,484 | 100,470 | 103,899 | 98,297 | 94,740 | 85,618 | 87,253 | 81,017 | 80,507 | 79,426 | 79,617 | 79,413 | 78,650 | 77,542 | 78,145 | 77,448 | 76,068 | 60,526 | ||||||||||||||||||||||||||||||||
diluted | 129,166 | 128,101 | 128,415 | 127,949 | 127,376 | 126,658 | 126,953 | 126,405 | 126,111 | 125,502 | 125,687 | 125,356 | 125,026 | 124,217 | 124,425 | 124,068 | 123,630 | 119,962 | 122,559 | 131,237 | 116,199 | 111,794 | 119,191 | 107,887 | 104,484 | 103,615 | 107,880 | 102,336 | 94,740 | 91,568 | 90,899 | 90,168 | 80,507 | 79,426 | 79,617 | 79,413 | 78,650 | 77,542 | 78,145 | 77,448 | 76,068 | 60,526 | ||||||||||||||||||||||||||||||||
restructuring charges | 1,707,000 | 1,009,000 | 1,544,000 | 2,398,000 | 1,205,000 | 2,125,000 | 3,074,000 | 4,684,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment charges | 626,000 | 7,086,000 | 20,041,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax benefit | -724,000 | -804,000 | -150,000 | -375,000 | -620,000 | -960,000 | -2,935,000 | -2,309,000 | -2,925,000 | -2,837,000 | -2,772,000 | -5,730,000 | -2,445,000 | -2,822,000 | -2,437,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
clinical services | 105,426,500 | 145,783,000 | 141,388,000 | 134,535,000 | 130,058,000 | 127,553,000 | 123,156,000 | 114,869,000 | 108,166,000 | 106,162,000 | 105,635,000 | 98,791,000 | 104,053,000 | 102,227,000 | 101,405,000 | 96,487,000 | 106,738,000 | 108,733,000 | 73,884,000 | 92,982,000 | 93,404,000 | 92,565,000 | 88,982,000 | 86,210,000 | 65,913,000 | 59,449,000 | 59,540,000 | |||||||||||||||||||||||||||||||||||||||||||||||
advanced diagnostics | 16,715,000 | 22,041,000 | 23,114,000 | 21,705,000 | 25,494,000 | 24,401,000 | 23,761,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total net revenue | 122,141,500 | 167,824,000 | 164,502,000 | 156,240,000 | 155,552,000 | 151,954,000 | 146,917,000 | 137,220,000 | 138,705,000 | 128,782,000 | 125,072,000 | 117,169,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
yoy | -21.48% | 10.44% | 11.97% | 13.86% | 12.15% | 17.99% | 17.47% | 17.11% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
qoq | -27.22% | 2.02% | 5.29% | 0.44% | 2.37% | 3.43% | 7.07% | -1.07% | 7.71% | 2.97% | 6.74% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
pharma services | 22,351,000 | 30,539,000 | 22,620,000 | 19,437,000 | 18,378,000 | 21,679,000 | 19,113,000 | 20,319,000 | 19,046,000 | 19,259,000 | 16,711,000 | 13,093,000 | 13,048,000 | 13,464,000 | 12,107,000 | 12,731,000 | 9,367,000 | 10,562,000 | 9,647,000 | 8,206,000 | 6,452,000 | 8,713,000 | 6,866,000 | 6,299,000 | 4,986,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
gain on investment in and loan receivable from non-consolidated affiliate | -17,750,000 | -96,534,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income before taxes | -33,454,500 | -39,624,000 | -41,033,000 | -44,204,000 | -23,170,000 | 73,436,000 | 7,567,000 | 2,222,000 | -17,956,000 | 2,435,000 | 3,491,000 | 2,166,000 | -4,447,000 | 1,402,000 | 2,077,000 | -737,000 | 1,082,000 | -1,584,000 | -4,760,000 | -97,000 | -1,479,000 | -8,424,000 | -73,000 | 745,000 | 329,000 | 1,126,000 | -291,000 | 325,000 | 963,000 | 929,000 | 273,000 | |||||||||||||||||||||||||||||||||||||||||||
adjustment to net income for convertible notes in diluted eps | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
convertible note accretion, amortization, and interest, net of tax | 1,552,000 | 1,975,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income used in diluted eps | -35,303,000 | 8,353,000 | -20,348,000 | 77,425,000 | -2,811,250 | 4,532,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other expenses | -168,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net revenue: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total revenue | 89,649,250 | 121,340,000 | 121,724,000 | 115,533,000 | 79,612,750 | 125,444,000 | 86,977,000 | 106,030,000 | 106,868,000 | 104,672,000 | 101,713,000 | 95,577,000 | 76,475,000 | 69,096,000 | 67,746,000 | 63,423,000 | 67,793,000 | 63,052,000 | 66,090,000 | 61,676,000 | 60,490,000 | 60,761,000 | 63,129,000 | 59,704,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
other income | -107,750 | -89,000 | -171,000 | -63,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on extinguishment of debt | 1,400,000 | 1,018,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on termination of cash flow hedge | 3,506,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustment to the numerator for convertible notes in diluted eps | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deemed dividends on preferred stock and amortization of beneficial conversion feature | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on redemption of preferred stock | -9,075,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to common stockholders | 6,296,000 | 2,143,000 | 1,991,000 | -2,424,000 | 353,000 | 2,023,000 | 5,924,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income per share attributable to common stockholders | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 0.06 | 0.02 | 0.02 | -0.03 | 0.018 | 0.02 | 0.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 0.06 | 0.02 | 0.02 | -0.03 | 0.015 | 0.02 | 0.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average common shares outstanding: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 129,166 | 128,101 | 128,415 | 127,949 | 127,376 | 126,658 | 126,953 | 126,405 | 126,111 | 125,502 | 125,687 | 125,356 | 125,026 | 124,217 | 124,425 | 124,068 | 123,630 | 119,962 | 122,559 | 118,287 | 116,199 | 108,579 | 110,461 | 107,887 | 104,484 | 100,470 | 103,899 | 98,297 | 94,740 | 85,618 | 87,253 | 81,017 | 80,507 | 79,426 | 79,617 | 79,413 | 78,650 | 77,542 | 78,145 | 77,448 | 76,068 | 60,526 | ||||||||||||||||||||||||||||||||
diluted | 129,166 | 128,101 | 128,415 | 127,949 | 127,376 | 126,658 | 126,953 | 126,405 | 126,111 | 125,502 | 125,687 | 125,356 | 125,026 | 124,217 | 124,425 | 124,068 | 123,630 | 119,962 | 122,559 | 131,237 | 116,199 | 111,794 | 119,191 | 107,887 | 104,484 | 103,615 | 107,880 | 102,336 | 94,740 | 91,568 | 90,899 | 90,168 | 80,507 | 79,426 | 79,617 | 79,413 | 78,650 | 77,542 | 78,145 | 77,448 | 76,068 | 60,526 | ||||||||||||||||||||||||||||||||
deemed dividends on preferred stock | 8,248,000 | 947,000 | 1,003,000 | 911,000 | 912,000 | 929,000 | 894,000 | 12,491,000 | 1,840,000 | 1,840,000 | 1,840,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of preferred stock beneficial conversion feature | -8,248,000 | 1,824,000 | 1,853,000 | 1,780,000 | 1,739,000 | 1,710,000 | 1,672,000 | -4,517,000 | 3,727,000 | 3,727,000 | 3,727,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of path logic | 1,058,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
clinical testing | 56,971,000 | 43,167,000 | 56,186,000 | 59,791,000 | 56,690,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net loss attributable to common stockholders | -2,212,000 | 2,260,000 | -7,751,000 | -2,682,000 | -3,220,000 | -4,050,000 | -5,634,000 | -5,154,000 | -5,412,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gross margin | 27,196,000 | 27,257,000 | 27,345,000 | 28,605,000 | 27,173,000 | 12,228,000 | 11,171,000 | 10,813,000 | 9,544,000 | 8,709,000 | 7,246,000 | 7,144,000 | 3,865,000 | 4,074,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
clinical testing revenue | 41,668,500 | 55,739,000 | 56,316,000 | 54,622,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
pharma services & research revenue | 4,229,750 | 5,022,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
biopharma & research revenue | 6,813,000 | 5,082,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest and other expense – net | -155,750 | -239,000 | -189,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income before income taxes | -260,500 | -125,000 | -161,000 | -756,000 | 129,000 | 20,000 | 603,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income taxes | 5,000 | 15,000 | 5,000 | 79,000 | 51,000 | 27,000 | 106,000 | 29,000 | 17,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income per share | -0.005 | -0.01 | -0.01 | -0.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average number of shares outstanding – basic | 60,537 | 60,425 | 60,277 | 53,483 | 48,263 | 45,027,010 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average number of shares outstanding – diluted | 60,537 | 60,425 | 60,277 | 56,016 | 52,775 | 48,715,063 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest and other expense - net | 195,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest and other income – net | -184,000 | -218,000 | -253,000 | -187,250 | -231,000 | -232,000 | -309,000 | -291,000 | -288,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
- basic | 12,818 | -0.01 | 0.01 | 49,277 | 0.005 | 0.02 | 0.01 | 46,264 | 11,236 | -0.02 | 0.01 | -0.03 | -0.02 | 33,066,941 | 32,173,698 | -0.01 | 31,367,144 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
- diluted | 13,481.5 | -0.01 | 0.01 | 53,469 | 0.005 | 0.02 | 0.01 | 50,923 | 12,056.5 | -0.02 | 0.01 | -0.03 | -0.02 | 38,485,914 | 35,630,058 | -0.01 | 38,243,857 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted avg number of shares outstanding | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest income—net | -265,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average number of shares outstanding | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest income - net | -285,000 | -258,000 | -182,000 | -159,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income before taxes | 44,500 | -975,000 | 551,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
– basic | 0.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
– diluted | 0.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit for income taxes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest and other income — net | -136,250 | -185,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
— basic and diluted | -0.008 | 43,103,707 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest and other income - net | -179,000 | -186 | -181 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
- basic and diluted | -0.01 | -0.02 | -0.03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted average number of shares outstanding | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income (loss) from operations | -797 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income / (loss) from operations | -591,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
— basic | -0.005 | -0.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
— diluted | -0.005 | -0.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
selling, general and administrative | 3,936,779 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income (loss) per share | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other operating expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted average number of shares outstanding – basic and fully diluted | 31,400,947 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average number of shares outstanding – basic and fully diluted | 31,400,947 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-05-13 | 2008-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 146,143,000 | 159,618,000 | 164,117,000 | 154,723,000 | 346,194,000 | 367,012,000 | 361,992,000 | 355,085,000 | 331,914,000 | 342,488,000 | 306,239,000 | 289,074,000 | 275,609,000 | 263,180,000 | 266,126,000 | 283,637,000 | 305,896,000 | 316,827,000 | 340,565,000 | 368,796,000 | 611,970,000 | 228,713,000 | 233,233,000 | 295,281,000 | 86,254,000 | 173,016,000 | 178,891,000 | 167,436,000 | 13,195,000 | 9,811,000 | 118,440,000 | 9,435,000 | 15,173,000 | 12,821,000 | 12,211,000 | 10,932,000 | 11,036,000 | 12,525,000 | 28,935,000 | 21,786,000 | 19,256,000 | 23,420,000 | 33,966,000 | 32,952,000 | 31,248,000 | 33,689,000 | 34,366,000 | 5,023,000 | 5,385,000 | 4,834,000 | 4,929,000 | 4,636,000 | 4,628,000 | 1,868,000 | 2,038,000 | 2,566,000 | 2,756,000 | 2,628,000 | 2,649,000 | 2,632,000 | 2,533,000 | 1,097,000 | 1,555,000 | 2,177,000 | 1,661,000 | 1,631,069 | 3,128,047 | 697,722 | 857,190 | 468,171 | 631,365 | 442,187 | 330,358 | 330,358 |
accounts receivable | 167,424,000 | 159,242,000 | 155,296,000 | 153,125,000 | 151,208,000 | 150,540,000 | 151,428,000 | 146,581,000 | 140,279,000 | 131,227,000 | 132,640,000 | 125,425,000 | 118,842,000 | 119,711,000 | 111,994,000 | 111,276,000 | 110,796,000 | 112,130,000 | 104,964,000 | 106,284,000 | 102,922,000 | 106,843,000 | 103,697,000 | 87,766,000 | 99,972,000 | 94,242,000 | 91,133,000 | 89,991,000 | 82,585,000 | 76,919,000 | 62,694,000 | 60,765,000 | 58,129,000 | 60,427,000 | 62,723,000 | 61,750,000 | 61,718,000 | 55,512,000 | 50,184,000 | 53,513,000 | 50,088,000 | 48,943,000 | 21,556,000 | 21,130,000 | 21,484,000 | 20,475,000 | 18,297,000 | 18,800,000 | 19,262,000 | 18,653,000 | 15,727,000 | 16,005,000 | 15,628,000 | 14,034,000 | 12,013,000 | 11,327,000 | 10,683,000 | 7,894,000 | 7,366,000 | 7,155,000 | 6,191,000 | 5,236,000 | 5,630,000 | 5,385,000 | 5,492,000 | 4,632,219 | 4,174,624 | 4,171,363 | 3,955,266 | 2,913,531 | 3,381,066 | 3,641,822 | 2,937,905 | 2,937,905 |
inventories | 29,837,000 | 28,566,000 | 28,460,000 | 34,171,000 | 29,772,000 | 26,748,000 | 24,457,000 | 23,214,000 | 20,320,000 | 24,156,000 | 24,053,000 | 24,945,000 | 24,432,000 | 24,277,000 | 23,799,000 | 21,863,000 | 23,840,000 | 23,395,000 | 21,834,000 | 21,384,000 | 21,382,000 | 29,526,000 | 20,643,000 | 21,627,000 | 20,286,000 | 14,405,000 | 12,632,000 | 8,733,000 | 9,670,000 | 8,650,000 | 6,829,000 | 6,898,000 | 7,515,000 | 7,474,000 | 6,088,000 | 5,457,000 | 5,970,000 | 6,253,000 | 5,952,000 | 5,545,000 | 5,334,000 | 5,108,000 | 2,967,000 | 3,416,000 | 2,595,000 | 2,616,000 | 2,970,000 | 2,616,000 | 2,003,000 | 2,301,000 | 2,068,000 | 1,738,000 | 1,646,000 | 1,859,000 | 1,906,000 | 1,526,000 | 1,312,000 | 1,202,000 | 1,096,000 | 1,079,000 | 911,000 | 887,000 | 768,000 | 807,000 | 582,000 | 601,802 | 613,631 | 598,612 | 577,730 | 491,459 | 344,608 | 364,259 | 245,986 | 245,986 |
prepaid assets | 23,666,000 | 21,443,000 | 21,986,000 | 22,831,000 | 22,980,000 | 20,165,000 | 18,235,000 | 17,396,000 | 19,155,000 | 17,987,000 | 18,676,000 | 16,571,000 | 16,185,000 | 15,237,000 | 16,511,000 | 16,662,000 | 14,341,000 | 12,354,000 | 14,618,000 | 13,959,000 | 11,073,000 | 11,547,000 | 10,459,000 | 8,300,000 | 6,884,000 | 6,327,000 | 8,742,000 | 9,553,000 | 7,504,000 | 7,727,000 | ||||||||||||||||||||||||||||||||||||||||||||
other current assets | 6,614,000 | 7,417,000 | 10,528,000 | 9,785,000 | 11,892,000 | 11,722,000 | 8,308,000 | 9,157,000 | 9,312,000 | 8,239,000 | 9,317,000 | 8,433,000 | 7,622,000 | 8,077,000 | 7,516,000 | 6,506,000 | 20,693,000 | 8,189,000 | 15,755,000 | 8,422,000 | 4,675,000 | 4,555,000 | 3,968,000 | 6,026,000 | 2,046,000 | 2,748,000 | 603,000 | 632,000 | 2,991,000 | 561,000 | 6,307,000 | 6,161,000 | 6,954,000 | 4,241,000 | 4,725,000 | 5,218,000 | 5,857,000 | 4,535,000 | 7,488,000 | 6,665,000 | 6,525,000 | 4,889,000 | 1,547,000 | 1,282,000 | 1,183,000 | 1,141,000 | 1,022,000 | 1,055,000 | 909,000 | 1,115,000 | 1,103,000 | 784,000 | 841,000 | 820,000 | 864,000 | 837,000 | 937,000 | 954,000 | 702,000 | 657,000 | 619,000 | 1,018,000 | 732,000 | 653,000 | 515,000 | 655,046 | 714,278 | 635,272 | 497,158 | 482,408 | 900,146 | 746,209 | 426,739 | 426,739 |
total current assets | 373,684,000 | 376,286,000 | 382,465,000 | 392,553,000 | 573,932,000 | 596,019,000 | 590,241,000 | 584,203,000 | 573,896,000 | 596,812,000 | 586,950,000 | 584,720,000 | 584,996,000 | 605,291,000 | 603,360,000 | 622,260,000 | 651,100,000 | 681,508,000 | 709,930,000 | 721,795,000 | 942,732,000 | 448,730,000 | 422,375,000 | 419,000,000 | 215,442,000 | 290,738,000 | 292,001,000 | 276,345,000 | 115,945,000 | 103,668,000 | 194,270,000 | 83,259,000 | 87,771,000 | 84,963,000 | 85,747,000 | 83,357,000 | 84,581,000 | 78,825,000 | 92,559,000 | 87,509,000 | 81,203,000 | 99,028,000 | 60,857,000 | 59,601,000 | 57,331,000 | 58,742,000 | 57,243,000 | 28,082,000 | 28,147,000 | 27,491,000 | 23,827,000 | 23,163,000 | 22,743,000 | 18,581,000 | 17,121,000 | 16,556,000 | 15,988,000 | 13,178,000 | 12,313,000 | 12,023,000 | 10,754,000 | 8,738,000 | 9,185,000 | 9,522,000 | 9,250,000 | 8,520,136 | 8,630,580 | 6,102,969 | 5,887,344 | 4,355,569 | 5,257,185 | 5,194,477 | 3,940,988 | 3,940,988 |
property and equipment | 83,659,000 | 84,834,000 | 85,470,000 | 85,462,000 | 89,603,000 | 94,103,000 | 93,038,000 | 92,158,000 | 87,865,000 | 92,012,000 | 94,517,000 | 100,110,000 | 102,845,000 | 102,499,000 | 106,818,000 | 111,105,000 | 108,942,000 | 109,465,000 | 107,172,000 | 112,208,000 | 94,315,000 | 85,873,000 | 85,449,000 | 83,969,000 | 83,392,000 | 64,188,000 | 62,488,000 | 59,334,000 | 60,696,000 | 60,888,000 | 41,004,000 | 42,873,000 | 36,504,000 | 34,549,000 | 35,588,000 | 36,531,000 | 34,036,000 | 34,169,000 | 33,575,000 | 33,559,000 | 34,577,000 | 15,898,000 | 16,286,000 | 16,640,000 | 15,082,000 | 14,637,000 | 12,974,000 | 11,472,000 | 9,694,000 | 8,592,000 | 8,437,000 | 8,045,000 | 8,607,000 | 9,234,000 | 8,410,000 | 7,355,000 | 6,642,000 | 5,062,000 | 4,559,000 | 4,553,000 | 4,839,000 | 5,010,000 | 5,042,000 | 4,882,000 | 4,339,560 | 4,180,162 | 3,190,587 | 2,857,025 | 2,875,297 | 2,495,146 | 2,215,613 | 2,032,537 | 2,032,537 | |
operating lease right-of-use assets | 76,703,000 | 78,444,000 | 80,150,000 | 82,870,000 | 77,803,000 | 79,583,000 | 81,442,000 | 83,671,000 | 86,578,000 | 91,769,000 | 87,131,000 | 91,412,000 | 93,784,000 | 96,109,000 | 98,945,000 | 99,917,000 | 101,955,000 | 102,197,000 | 102,310,000 | 54,558,000 | 50,904,000 | 45,786,000 | 45,856,000 | 47,554,000 | 49,084,000 | 26,492,000 | 25,797,000 | 26,057,000 | 19,734,000 | |||||||||||||||||||||||||||||||||||||||||||||
intangible assets | 278,895,000 | 286,528,000 | 294,162,000 | 301,795,000 | 331,319,000 | 339,681,000 | 348,042,000 | 356,404,000 | 364,764,000 | 373,128,000 | 381,910,000 | 390,693,000 | 399,477,000 | 408,260,000 | 416,848,000 | 425,338,000 | 433,835,000 | 442,325,000 | 450,802,000 | 471,038,000 | 118,195,000 | 120,653,000 | 123,353,000 | 125,821,000 | 128,289,000 | 126,640,000 | 129,084,000 | 135,301,000 | 137,844,000 | 140,029,000 | 69,909,000 | 71,330,000 | 72,751,000 | 74,165,000 | 76,330,000 | 73,614,000 | 75,339,000 | 77,064,000 | 82,346,000 | 84,164,000 | 85,774,000 | 87,800,000 | 3,928,000 | 4,022,000 | 4,119,000 | 4,212,000 | 4,236,000 | 2,466,000 | 2,521,000 | 2,577,000 | 2,633,000 | 2,689,000 | 2,744,000 | 2,800,000 | 2,856,000 | 2,912,000 | 2,968,000 | |||||||||||||||||
goodwill | 523,995,000 | 524,344,000 | 524,344,000 | 524,143,000 | 522,766,000 | 522,766,000 | 522,766,000 | 522,766,000 | 522,766,000 | 522,766,000 | 522,766,000 | 522,766,000 | 522,766,000 | 522,766,000 | 522,766,000 | 527,115,000 | 527,115,000 | 527,115,000 | 525,802,000 | 499,977,000 | 211,083,000 | 211,083,000 | 210,833,000 | 210,833,000 | 210,833,000 | 198,601,000 | 198,571,000 | 196,298,000 | 196,298,000 | 197,892,000 | 147,019,000 | 147,019,000 | 147,019,000 | 147,019,000 | 147,019,000 | 147,019,000 | 147,019,000 | 147,019,000 | 146,179,000 | 146,179,000 | 146,179,000 | 146,421,000 | 2,929,000 | 2,929,000 | 2,929,000 | 2,929,000 | 2,561,000 | |||||||||||||||||||||||||||
other assets | 9,595,000 | 9,394,000 | 8,189,000 | 7,127,000 | 6,007,000 | 5,886,000 | 5,582,000 | 4,075,000 | 4,470,000 | 4,742,000 | 4,967,000 | 5,407,000 | 5,306,000 | 5,109,000 | 6,845,000 | 6,378,000 | 6,600,000 | 7,168,000 | 7,210,000 | 7,674,000 | 5,273,000 | 4,503,000 | 3,817,000 | 3,057,000 | 3,153,000 | 2,847,000 | 3,214,000 | 3,332,000 | 2,826,000 | 2,538,000 | 2,937,000 | 1,302,000 | 1,320,000 | 689,000 | 250,000 | 302,000 | 167,000 | 174,000 | 174,000 | 129,000 | 129,000 | 129,000 | 129,000 | 128,000 | 139,000 | 141,000 | 143,000 | 116,000 | 179,000 | 154,000 | 178,000 | 170,000 | 84,000 | 83,000 | 91,000 | 123,000 | 129,000 | 129,000 | 93,000 | 74,000 | 86,000 | 87,000 | 86,000 | 85,604 | 106,737 | 88,283 | 72,791 | 64,509 | 275,087 | 255,566 | 248,374 | 248,374 | ||
total non-current assets | 972,847,000 | 983,544,000 | 992,315,000 | 1,001,397,000 | 1,027,498,000 | 1,042,019,000 | 1,050,870,000 | 1,059,074,000 | 1,066,443,000 | 1,084,417,000 | 1,091,291,000 | 1,110,388,000 | 1,124,178,000 | 1,134,743,000 | 1,152,222,000 | 1,169,853,000 | 1,178,447,000 | 1,188,270,000 | 1,196,457,000 | 1,174,516,000 | 551,681,000 | 539,601,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
total assets | 1,346,531,000 | 1,359,830,000 | 1,374,780,000 | 1,393,950,000 | 1,601,430,000 | 1,638,038,000 | 1,641,111,000 | 1,643,277,000 | 1,640,339,000 | 1,681,229,000 | 1,678,241,000 | 1,695,108,000 | 1,709,174,000 | 1,740,034,000 | 1,755,582,000 | 1,792,113,000 | 1,829,547,000 | 1,869,778,000 | 1,906,387,000 | 1,896,311,000 | 1,494,413,000 | 988,331,000 | 959,428,000 | 945,485,000 | 732,247,000 | 709,506,000 | 711,155,000 | 696,667,000 | 533,343,000 | 505,015,000 | 455,139,000 | 345,783,000 | 349,272,000 | 343,340,000 | 343,895,000 | 339,880,000 | 343,637,000 | 337,118,000 | 355,427,000 | 351,556,000 | 346,844,000 | 367,955,000 | 83,741,000 | 82,966,000 | 81,158,000 | 81,106,000 | 78,820,000 | 43,638,000 | 42,319,000 | 39,916,000 | 35,230,000 | 34,459,000 | 33,616,000 | 30,071,000 | 29,302,000 | 28,001,000 | 26,440,000 | 19,949,000 | 17,485,000 | 16,658,000 | 15,400,000 | 13,651,000 | 14,281,000 | 14,651,000 | 14,218,000 | 12,945,300 | 12,917,479 | 9,381,839 | 8,817,160 | 7,295,375 | 8,027,418 | 7,665,656 | 6,221,899 | 6,221,899 |
liabilities and stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable | 25,898,000 | 23,090,000 | 22,611,000 | 27,492,000 | 16,211,000 | 21,607,000 | 16,514,000 | 17,186,000 | 18,336,000 | 20,334,000 | 16,819,000 | 17,913,000 | 22,712,000 | 20,510,000 | 13,708,000 | 16,849,000 | 20,481,000 | 17,921,000 | 28,536,000 | 23,056,000 | 18,919,000 | 24,965,000 | 17,735,000 | 19,198,000 | 20,453,000 | 19,568,000 | 17,995,000 | 16,326,000 | 16,514,000 | 17,779,000 | 9,200,000 | 12,337,000 | 13,048,000 | 10,450,000 | 14,823,000 | 15,594,000 | 20,579,000 | 16,782,000 | 13,984,000 | 13,435,000 | 15,288,000 | 12,464,000 | 5,026,000 | 6,059,000 | 5,465,000 | 6,294,000 | 6,287,000 | 6,081,000 | 4,701,000 | 4,177,000 | 3,780,000 | 3,387,000 | 2,925,000 | 3,611,000 | 3,238,000 | 3,134,000 | 3,316,000 | 2,529,000 | 2,285,000 | 2,463,000 | 1,722,000 | 1,933,000 | 1,869,000 | 2,049,000 | 1,762,000 | 1,968,884 | 2,106,696 | 1,554,015 | 1,695,518 | 1,512,427 | 1,904,694 | 1,902,813 | 1,609,775 | 1,609,775 |
accrued compensation | 40,576,000 | 47,580,000 | 51,301,000 | 48,557,000 | 39,487,000 | 62,443,000 | 52,165,000 | 50,880,000 | 34,609,000 | 53,161,000 | 47,594,000 | 45,686,000 | 32,891,000 | 40,141,000 | 37,992,000 | 37,280,000 | 32,320,000 | 38,304,000 | 32,283,000 | 38,719,000 | 23,621,000 | 24,727,000 | 26,083,000 | 22,065,000 | 20,810,000 | 21,365,000 | 26,298,000 | 19,621,000 | 18,851,000 | 19,062,000 | 15,187,000 | 11,184,000 | 10,164,000 | 9,482,000 | 11,805,000 | 7,782,000 | 7,697,000 | 8,351,000 | 11,382,000 | 8,577,000 | 9,185,000 | 6,217,000 | 4,767,000 | 3,940,000 | 3,394,000 | 3,897,000 | 3,410,000 | 3,411,000 | 2,210,000 | 2,337,000 | 2,375,000 | 2,291,000 | 1,889,000 | 2,808,000 | 2,194,000 | 2,314,000 | 1,617,000 | 2,137,000 | 1,291,000 | 1,401,000 | 907,000 | 1,338,000 | 1,083,000 | 1,275,000 | 1,007,000 | 1,308,160 | 736,552 | |||||||
accrued expenses and other liabilities | 12,727,000 | 12,003,000 | 17,393,000 | 18,479,000 | 18,628,000 | 12,624,000 | 22,998,000 | 17,274,000 | 18,134,000 | 15,069,000 | 18,679,000 | 18,172,000 | 17,964,000 | 15,070,000 | 20,420,000 | 16,075,000 | 16,571,000 | 17,796,000 | 18,088,000 | 25,304,000 | 14,018,000 | 11,654,000 | 8,677,000 | 7,913,000 | 8,966,000 | 7,548,000 | 7,900,000 | 7,893,000 | 8,986,000 | 7,517,000 | 9,889,000 | 9,884,000 | 6,144,000 | 5,000,000 | 3,186,000 | 2,766,000 | 4,247,000 | 4,380,000 | 7,604,000 | 4,980,000 | 7,374,000 | 1,332,000 | 1,231,000 | 1,237,000 | 1,208,000 | 741,000 | 669,000 | 690,000 | 691,000 | 818,000 | 773,000 | 426,000 | 460,000 | 622,000 | 508,000 | 439,000 | 464,830 | 1,200,988 | 1,220,807 | 1,328,220 | 358,265 | 955,405 | 1,203,374 | 1,280,212 | 1,280,212 | |||||||||
current portion of operating lease liabilities | 4,828,000 | 4,776,000 | 4,507,000 | 4,052,000 | 3,075,000 | 3,381,000 | 3,716,000 | 3,574,000 | 4,487,000 | 5,610,000 | 6,213,000 | 7,354,000 | 6,934,000 | 6,584,000 | 6,379,000 | 5,708,000 | 5,958,000 | 6,884,000 | 6,988,000 | 5,642,000 | 5,111,000 | 4,967,000 | 3,620,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
contract liabilities | 561,000 | 851,000 | 1,576,000 | 1,084,000 | 1,163,000 | 409,000 | 589,000 | 972,000 | 1,144,000 | 2,130,000 | 3,617,000 | 5,712,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total current liabilities | 84,590,000 | 88,300,000 | 97,866,000 | 100,120,000 | 279,695,000 | 301,241,000 | 296,406,000 | 289,959,000 | 76,710,000 | 96,304,000 | 92,926,000 | 94,848,000 | 86,606,000 | 89,932,000 | 85,003,000 | 82,670,000 | 82,070,000 | 87,232,000 | 92,737,000 | 99,131,000 | 67,750,000 | 73,183,000 | 64,612,000 | 61,700,000 | 67,649,000 | 63,904,000 | 68,907,000 | 59,162,000 | 72,703,000 | 60,925,000 | 47,055,000 | 47,974,000 | 43,303,000 | 35,065,000 | 40,114,000 | 35,204,000 | 39,876,000 | 38,113,000 | 35,392,000 | 34,953,000 | 34,316,000 | 40,058,000 | 15,328,000 | 15,125,000 | 13,855,000 | 14,623,000 | 13,954,000 | 15,226,000 | 15,227,000 | 14,323,000 | 12,246,000 | 12,056,000 | 11,949,000 | 17,758,000 | 16,670,000 | 15,096,000 | 14,749,000 | 11,444,000 | 10,539,000 | 10,112,000 | 8,799,000 | 9,168,000 | 9,517,000 | 8,832,000 | 7,484,000 | 5,776,233 | 4,303,616 | 5,503,061 | 5,152,506 | 4,390,994 | 4,486,096 | 4,480,340 | 3,178,402 | 3,178,402 |
long-term liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating lease liabilities | 61,461,000 | 62,822,000 | 64,325,000 | 66,616,000 | 59,861,000 | 60,841,000 | 62,172,000 | 63,294,000 | 64,773,000 | 67,871,000 | 62,007,000 | 65,468,000 | 67,319,000 | 68,952,000 | 70,471,000 | 71,882,000 | 73,434,000 | 72,289,000 | 72,336,000 | 49,624,000 | 46,437,000 | 42,296,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
convertible senior notes | 342,240,000 | 341,858,000 | 341,476,000 | 341,095,000 | 340,714,000 | 340,335,000 | 339,956,000 | 339,577,000 | 538,923,000 | 538,198,000 | 537,475,000 | 536,755,000 | 536,037,000 | 535,322,000 | 534,609,000 | 533,898,000 | 533,189,000 | 532,483,000 | 531,779,000 | 531,077,000 | 530,378,000 | 168,120,000 | 166,440,000 | 164,544,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
deferred income tax liabilities | 17,450,000 | 18,219,000 | 20,846,000 | 19,976,000 | 20,970,000 | 21,510,000 | 22,771,000 | 23,015,000 | 23,490,000 | 24,285,000 | 25,370,000 | 28,811,000 | 31,715,000 | 34,750,000 | 38,345,000 | 45,979,000 | 51,709,000 | 55,475,000 | 57,706,000 | 63,877,000 | 1,744,000 | 5,415,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
other long-term liabilities | 12,030,000 | 12,069,000 | 11,977,000 | 12,103,000 | 11,921,000 | 11,772,000 | 11,596,000 | 11,548,000 | 13,033,000 | 13,034,000 | 13,035,000 | 13,034,000 | 13,035,000 | 13,055,000 | 14,166,000 | 14,165,000 | 14,141,000 | 13,951,000 | 14,432,000 | 3,796,000 | 3,707,000 | 4,056,000 | 3,937,000 | 3,155,000 | 3,566,000 | 3,060,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
total long-term liabilities | 433,181,000 | 434,968,000 | 438,624,000 | 439,790,000 | 433,466,000 | 434,458,000 | 436,495,000 | 437,434,000 | 640,219,000 | 643,388,000 | 637,887,000 | 644,068,000 | 648,106,000 | 652,079,000 | 657,591,000 | 665,924,000 | 672,473,000 | 674,269,000 | 676,405,000 | 648,822,000 | 582,949,000 | 220,854,000 | 228,453,000 | 229,556,000 | 159,555,000 | 138,194,000 | 145,241,000 | 147,771,000 | 136,792,000 | 123,647,000 | 104,525,000 | 133,600,000 | 97,953,000 | 102,742,000 | 104,123,000 | 108,102,000 | 109,737,000 | 112,409,000 | 73,943,000 | 73,235,000 | 72,356,000 | 89,785,000 | 6,564,000 | 6,974,000 | 7,148,000 | |||||||||||||||||||||||||||||
total liabilities | 517,771,000 | 523,268,000 | 536,490,000 | 539,910,000 | 713,161,000 | 735,699,000 | 732,901,000 | 727,393,000 | 716,929,000 | 739,692,000 | 730,813,000 | 738,916,000 | 734,712,000 | 742,011,000 | 742,594,000 | 748,594,000 | 754,543,000 | 761,501,000 | 769,142,000 | 747,953,000 | 650,699,000 | 294,037,000 | 293,065,000 | 291,256,000 | 227,204,000 | 202,098,000 | 214,148,000 | 206,933,000 | 209,495,000 | 184,572,000 | 151,580,000 | 181,574,000 | 141,256,000 | 137,807,000 | 144,237,000 | 143,306,000 | 149,613,000 | 150,522,000 | 109,335,000 | 108,188,000 | 106,672,000 | 129,843,000 | 21,892,000 | 22,099,000 | 21,003,000 | 20,701,000 | 19,755,000 | 20,505,000 | 19,824,000 | 18,205,000 | 14,903,000 | 15,019,000 | 14,786,000 | 20,855,000 | 20,080,000 | 18,282,000 | 17,770,000 | 14,052,000 | 12,125,000 | 11,369,000 | 10,014,000 | 10,516,000 | 10,906,000 | 10,268,000 | 9,115,000 | 7,301,961 | 5,869,960 | 7,034,007 | 6,523,840 | 5,794,265 | 5,540,417 | 5,334,633 | 4,068,870 | 4,068,870 |
commitments and contingencies | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock, 0.001 par value... | 129,000 | 129,000 | 128,000 | 128,000 | 128,000 | 128,000 | 128,000 | 128,000 | 127,000 | 127,000 | 127,000 | 127,000 | 127,000 | 127,000 | 127,000 | 126,000 | 125,000 | 124,000 | 123,000 | 123,000 | 117,000 | 112,000 | 111,000 | 110,000 | 105,000 | 105,000 | 104,000 | 104,000 | 95,000 | 94,000 | 93,000 | 81,000 | 81,000 | 80,000 | 79,000 | 79,000 | 78,000 | 78,000 | 61,000 | |||||||||||||||||||||||||||||||||||
additional paid-in capital | 1,279,539,000 | 1,270,235,000 | 1,262,016,000 | 1,250,679,000 | 1,239,901,000 | 1,228,198,000 | 1,219,182,000 | 1,209,536,000 | 1,198,729,000 | 1,190,139,000 | 1,181,876,000 | 1,172,850,000 | 1,167,051,000 | 1,160,882,000 | 1,154,365,000 | 1,146,997,000 | 1,142,133,000 | 1,123,628,000 | 1,110,590,000 | 1,101,298,000 | 872,350,000 | 701,357,000 | 688,832,000 | 679,235,000 | 525,929,000 | 520,278,000 | 516,936,000 | 543,484,000 | 378,571,000 | 372,186,000 | 354,487,000 | 217,451,000 | 232,039,000 | 230,030,000 | 229,006,000 | 220,622,000 | 217,626,000 | 216,104,000 | 238,975,000 | 236,183,000 | 233,401,000 | 231,375,000 | 82,256,000 | 81,148,000 | 80,262,000 | 79,751,000 | 79,457,000 | 43,244,000 | 42,880,000 | 42,200,000 | 41,673,000 | 41,686,000 | 41,349,000 | 31,742,000 | 31,635,000 | 31,157,000 | 30,659,000 | 28,490,000 | 28,105,000 | 27,891,000 | 27,696,000 | 24,557,000 | 24,420,000 | 24,229,000 | 23,972,000 | 23,761,784 | 23,637,244 | 18,186,334 | 18,139,903 | 17,381,810 | 17,373,756 | 17,022,971 | 16,917,216 | 16,917,216 |
accumulated other comprehensive income | 4,000 | 4,000 | 71,000 | 29,000 | -638,000 | -390,000 | -333,000 | -150,000 | -1,136,000 | -579,000 | 536,000 | 257,000 | 499,000 | 274,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated deficit | -450,912,000 | -433,806,000 | -423,925,000 | -396,796,000 | -351,704,000 | -325,781,000 | -310,457,000 | -292,758,000 | -274,116,000 | -247,055,000 | -232,729,000 | -214,213,000 | -189,882,000 | -159,087,000 | -136,400,000 | -99,548,000 | -64,245,000 | -14,837,000 | -28,603,000 | -7,185,000 | -22,602,000 | -25,159,000 | -18,335,000 | -11,357,000 | -17,653,000 | -51,691,000 | -53,682,000 | -51,258,000 | -51,557,000 | -53,580,000 | -60,074,000 | -57,466,000 | -59,553,000 | -51,803,000 | -49,120,000 | -52,460,000 | -38,263,000 | -32,628,000 | -27,475,000 | -21,941,000 | -20,468,000 | -20,342,000 | -20,167,000 | -19,406,000 | -20,452,000 | -20,161,000 | -20,435,000 | -20,538,000 | -21,395,000 | -22,295,000 | -22,568,000 | -22,571,000 | -22,458,000 | -21,483,000 | -22,034,000 | -22,636,000 | -22,788,000 | -22,645,000 | -22,353,000 | -21,459,000 | -21,082,000 | -19,883,000 | -18,906,000 | -18,155,630 | -16,626,885 | -15,871,579 | -15,879,639 | -15,912,817 | -14,918,441 | -14,723,316 | -14,795,594 | -14,795,594 | ||
total stockholders' equity | 828,760,000 | 838,290,000 | 854,040,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities and stockholders’ equity | 1,346,531,000 | 1,374,780,000 | 1,393,950,000 | 1,601,430,000 | 1,638,038,000 | 1,641,111,000 | 1,643,277,000 | 1,640,339,000 | 1,681,229,000 | 1,678,241,000 | 1,695,108,000 | 1,709,174,000 | 1,740,034,000 | 1,755,582,000 | 1,792,113,000 | 1,829,547,000 | 1,869,778,000 | 1,906,387,000 | 1,896,311,000 | 988,331,000 | 709,506,000 | 83,741,000 | 82,966,000 | 81,158,000 | 81,106,000 | 78,820,000 | 43,638,000 | 42,319,000 | 39,916,000 | 35,230,000 | 34,459,000 | 33,616,000 | 30,071,000 | 29,302,000 | 28,001,000 | 26,440,000 | 19,949,000 | 17,485,000 | 16,658,000 | 15,400,000 | 13,651,000 | 14,281,000 | 14,651,000 | 14,218,000 | 12,945,300 | 12,917,479 | 9,381,839 | 8,817,160 | 7,295,375 | 8,027,418 | 7,665,656 | 6,221,899 | 6,221,899 | |||||||||||||||||||||
marketable securities, at fair value | 8,962,000 | 11,886,000 | 19,832,000 | 25,821,000 | 32,770,000 | 52,916,000 | 72,715,000 | 96,025,000 | 120,272,000 | 142,306,000 | 174,809,000 | 177,414,000 | 182,316,000 | 175,534,000 | 198,563,000 | 202,144,000 | 202,950,000 | 190,710,000 | 67,546,000 | 50,375,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of convertible senior notes | 201,131,000 | 200,777,000 | 200,424,000 | 200,073,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total stockholders’ equity | 836,562,000 | 888,269,000 | 902,339,000 | 908,210,000 | 915,884,000 | 923,410,000 | 941,537,000 | 947,428,000 | 956,192,000 | 974,462,000 | 998,023,000 | 1,012,988,000 | 1,043,519,000 | 1,075,004,000 | 1,108,277,000 | 1,137,245,000 | 1,148,358,000 | 843,714,000 | 694,294,000 | 666,363,000 | 654,229,000 | 505,043,000 | 507,408,000 | 497,007,000 | 489,734,000 | 323,848,000 | 320,443,000 | 303,559,000 | 164,209,000 | 172,545,000 | 172,918,000 | 169,533,000 | 168,898,000 | 168,585,000 | 163,723,000 | 200,790,000 | 203,633,000 | 206,003,000 | 209,510,000 | 61,849,000 | 60,867,000 | 60,155,000 | 60,405,000 | 59,065,000 | 23,133,000 | 22,495,000 | 21,711,000 | 20,327,000 | 19,440,000 | 18,830,000 | 9,216,000 | 9,222,000 | 9,719,000 | 8,670,000 | 5,897,000 | 5,360,000 | 5,289,000 | 5,386,000 | 3,135,000 | 3,375,000 | 4,383,000 | 5,103,000 | 5,643,339 | 7,047,519 | 2,347,832 | 2,293,320 | 1,501,110 | 2,487,001 | 2,331,023 | 2,153,029 | 2,153,029 | |||
total liabilities and stockholders' equity | 1,359,830,000 | 1,494,413,000 | 959,428,000 | 945,485,000 | 732,247,000 | 711,155,000 | 696,667,000 | 533,343,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assets held for sale | 2,078,000 | 8,956,000 | 10,050,000 | 10,050,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities held for sale | 478,000 | 456,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive loss | -56,000 | -206,000 | -643,000 | -1,022,000 | -1,330,000 | -1,674,000 | -1,846,000 | -2,572,000 | -2,834,000 | -3,899,000 | -5,104,000 | -4,056,000 | -3,009,000 | 10,000 | 22,000 | 43,000 | -2,656,000 | -1,618,000 | -2,380,000 | -2,163,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of equipment financing obligations | 4,000 | 11,000 | 38,000 | 70,000 | 118,000 | 410,000 | 621,000 | 1,135,000 | 1,564,000 | 1,913,000 | 2,089,000 | 2,841,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
pharma contract liabilities | 6,067,000 | 7,557,000 | 6,386,000 | 6,348,000 | 6,119,000 | 5,192,000 | 5,278,000 | 4,497,000 | 3,992,000 | 4,029,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted cash | 3,161,000 | 4,103,000 | 11,119,000 | 21,919,000 | 300,000 | 300,000 | 300,000 | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 | 1,000,000 | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment in non-consolidated affiliate | 29,555,000 | 29,555,000 | 25,600,000 | 13,137,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid lease asset | 24,958,000 | 21,052,000 | 20,229,000 | 10,142,000 | 6,084,000 | 3,316,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equipment financing obligations | 71,000 | 152,000 | 448,000 | 683,000 | 967,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
retained earnings | 26,922,000 | 47,270,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loan receivable from non-consolidated affiliate | 10,185,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of term loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
term loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted cash, non-current | 32,003,000 | 36,030,000 | 38,738,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
short-term portion of financing obligations | 3,700,000 | 4,458,000 | 4,941,000 | 5,432,000 | 5,750,000 | 5,825,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
short-term portion of operating leases | 4,701,000 | 4,496,000 | 4,505,000 | 3,527,000 | 3,428,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
short-term portion of term loan | 5,000,000 | 5,000,000 | 6,250,000 | 5,000,000 | 7,873,000 | 3,750,000 | 3,750,000 | 550,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
pharma contract liability | 3,716,000 | 3,570,000 | 2,974,000 | 1,610,000 | 1,187,000 | 1,069,000 | 1,017,000 | 927,000 | 1,259,000 | 2,155,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term portion of financing obligations | 1,399,000 | 1,911,000 | 2,428,000 | 3,199,000 | 3,982,000 | 4,782,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term portion of operating leases | 43,123,000 | 44,524,000 | 45,910,000 | 23,870,000 | 24,179,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term portion of term loan | 90,605,000 | 91,829,000 | 93,027,000 | 87,880,000 | 66,616,000 | 70,149,000 | 52,254,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred income tax liability | 13,554,000 | 15,422,000 | 16,377,000 | 15,566,000 | 19,688,000 | 20,117,000 | 20,156,000 | 22,457,000 | 6,899,000 | 6,827,000 | 6,594,000 | 6,307,000 | 7,548,000 | 7,435,000 | 7,583,000 | 14,973,000 | 16,236,000 | 16,249,000 | 15,916,000 | 32,409,000 | 821,000 | 821,000 | 821,000 | 821,000 | 588,000 | 588,000 | 588,000 | 588,000 | ||||||||||||||||||||||||||||||||||||||||||||||
stockholders' equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other long term liabilities | 4,235,000 | 4,674,000 | 4,443,000 | 3,740,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
short-term portion of operating lease liabilities | 3,381,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term portion of operating lease liabilities | 24,034,000 | 16,648,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
revolving credit facility | 5,000,000 | 5,000,000 | 29,176,000 | 19,114,000 | 24,516,000 | 24,461,000 | 26,906,000 | 26,860,000 | 8,869,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term portion of term loans | 94,250,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued expenses and other current liabilities | 18,327,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of finance leases and obligations | 6,501,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of loans | 7,873,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term portion of finance leases and obligations | 5,253,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term portion of loans | 85,995,000 | 89,764,000 | 91,535,000 | 65,208,000 | 67,531,000 | 68,454,000 | 69,363,000 | 52,194,000 | 52,238,000 | 52,316,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies - see note l | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities, redeemable convertible preferred stock and stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
short-term portion of car loans | 49,000 | 92,000 | 50,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
short-term portion of capital leases | 6,298,000 | 5,190,000 | 4,687,000 | 4,812,000 | 4,997,000 | 4,891,000 | 5,000,000 | 4,691,000 | 4,267,000 | 4,534,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term portion of car loans | 20,000 | 110,000 | 82,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term portion of capital leases | 5,250,000 | 5,283,000 | 4,583,000 | 5,307,000 | 5,931,000 | 5,378,000 | 5,513,000 | 4,748,000 | 4,124,000 | 5,040,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies - see note m | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
redeemable convertible preferred stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
series a redeemable convertible preferred stock, 0.001 par value... | 35,471,000 | 32,615,000 | 30,125,000 | 27,676,000 | 25,439,000 | 45,302,000 | 39,735,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities, redeemable convertible preferred stock and stockholders' equity | 505,015,000 | 455,139,000 | 345,783,000 | 349,272,000 | 343,340,000 | 343,895,000 | 339,880,000 | 343,637,000 | 337,118,000 | 355,427,000 | 351,556,000 | 346,844,000 | 367,955,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
short-term portion of capital leases and car loans | 6,675,000 | 5,847,000 | 5,988,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
short-term portion of loans | 7,217,000 | 6,562,000 | 4,219,000 | 3,799,000 | 3,830,000 | 3,837,000 | 646,000 | 646,000 | 596,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term portion of capital leases and car loans | 6,663,000 | 5,414,000 | 6,515,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term pharma contract liability | 1,199,000 | 648,000 | 522,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies - see note i | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
property and equipment (net of accumulated depreciation of 44,024 and 40,530, respectively. | 40,411,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies - see note j | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock, .001 par value... | 80,000 | 79,000 | 77,000 | 76,000 | 61,000 | 60,000 | 60,000 | 60,000 | 50,000 | 50,000 | 49,000 | 49,000 | 49,000 | 49,000 | 45,000 | 45,000 | 45,000 | 45,000 | 43,000 | 43,000 | 43,000 | 43,000 | 37,000 | 37,000 | 37,000 | 37,000 | 37,185 | 37,160 | 33,077 | 33,056 | 32,117 | 31,686 | 31,368 | 31,407 | 31,407 | |||||||||||||||||||||||||||||||||||||||
series a redeemable convertible preferred stock, 0.01 par value... | 22,873,000 | 34,169,000 | 28,602,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred income tax asset | 16,668,000 | 821,000 | 821,000 | 821,000 | 821,000 | 588,000 | 588,000 | 588,000 | 588,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies - see note k | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
short-term portion of equipment capital lease obligations | 4,203,000 | 3,895,000 | 3,759,000 | 3,224,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term portion of equipment capital lease obligations | 5,743,000 | 6,153,000 | 6,327,000 | 5,257,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies (see note g) stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
revolving credit line | 1,989,000 | 4,864,000 | 4,282,000 | 2,736,000 | 3,193,000 | 4,190,000 | 8,458,000 | 8,035,000 | 6,393,000 | 6,686,000 | 3,898,000 | 4,472,000 | 3,819,000 | 3,863,000 | 3,442,000 | 3,900,000 | 2,969,000 | 2,453,000 | 552,033 | 1,858,187 | 1,419,033 | 1,146,850 | 1,176,221 | 1,053,471 | ||||||||||||||||||||||||||||||||||||||||||||||||||
long term liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total long term liabilities | 6,078,000 | 5,801,000 | 5,279,000 | 4,597,000 | 3,882,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other accrued expenses and liabilities | 1,100,000 | 651,000 | 461,000 | 755,000 | 631,000 | 662,000 | 625,000 | 573,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
short-term portion of equipment capital leases | 3,157,000 | 3,094,000 | 2,991,000 | 2,786,000 | 2,600,000 | 2,554,000 | 2,283,000 | 2,212,000 | 2,513,000 | 2,564,000 | 2,312,000 | 2,107,000 | 1,866,000 | 1,856,000 | 1,881,000 | 1,995,000 | 2,043,000 | 2,031,000 | 1,823,000 | 1,482,326 | 995,932 | 870,052 | 709,735 | 636,900 | 449,776 | 320,682 | 288,415 | 288,415 | ||||||||||||||||||||||||||||||||||||||||||||||
long-term portion of equipment capital leases and notes payable | 5,213,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term portion of equipment capital leases | 4,691,000 | 4,009,000 | 3,294,000 | 2,657,000 | 2,963,000 | 2,837,000 | 3,097,000 | 3,410,000 | 3,186,000 | 3,021,000 | 2,608,000 | 1,586,000 | 1,257,000 | 1,215,000 | 1,348,000 | 1,389,000 | 1,436,000 | 1,631,000 | 1,525,728 | 1,566,344 | 1,530,946 | 1,371,334 | 1,403,271 | 1,054,321 | 854,293 | 890,468 | 890,468 | |||||||||||||||||||||||||||||||||||||||||||||||
committments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deposits | 110,000 | 76,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
legal contingency |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-09-30 | 2008-06-30 | 2008-05-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net loss | -17,106,000 | -9,881,000 | -27,129,000 | -45,092,000 | -25,923,000 | -15,324,000 | -17,699,000 | -18,642,000 | -27,061,000 | -14,326,000 | -18,516,000 | -24,331,000 | -30,795,000 | -49,408,000 | -22,114,000 | -6,824,000 | -6,978,000 | -388,210 | -193,085 | -265,363 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net loss to net cash from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation | 8,780,000 | 8,763,000 | 8,803,000 | 9,140,000 | 9,366,000 | 9,827,000 | 9,623,000 | 9,746,000 | 9,905,000 | 9,578,000 | 9,349,000 | 9,475,000 | 9,048,000 | 9,478,000 | 8,973,000 | 8,526,000 | 8,395,000 | 8,385,000 | 8,178,000 | 6,949,000 | 6,680,000 | 7,199,000 | 6,528,000 | 5,937,000 | 6,240,000 | 5,146,000 | 4,848,000 | 5,081,000 | 5,271,000 | 4,327,000 | 4,033,000 | 3,811,000 | 3,633,000 | 3,857,000 | 3,833,000 | 3,927,000 | 3,979,000 | 4,387,000 | 4,221,000 | 3,744,000 | 3,585,000 | 521,000 | 475,000 | 488,000 | 459,000 | 423,000 | 415,000 | 310,849 | 265,943 | 237,059 | 512,913 | 323,720 | 156,416 | |||||||||||||||||||
amortization of intangibles | 7,633,000 | 7,632,000 | 7,634,000 | 8,124,000 | 8,362,000 | 8,361,000 | 8,362,000 | 8,361,000 | 8,362,000 | 8,783,000 | 8,784,000 | 8,783,000 | 8,783,000 | 8,588,000 | 8,491,000 | 8,489,000 | 8,490,000 | 8,477,000 | 8,474,000 | 3,751,000 | 2,458,000 | 2,430,000 | 2,468,000 | 2,467,000 | 2,452,000 | 2,443,000 | 2,380,000 | 2,543,000 | 2,559,000 | 1,673,000 | 1,421,000 | 1,421,000 | 1,413,000 | 1,794,000 | 1,751,000 | 1,725,000 | 1,725,000 | 1,818,000 | 1,818,000 | 1,610,000 | 2,026,000 | 129,000 | 93,000 | 97,000 | 93,000 | 95,000 | 89,000 | 55,000 | 56,000 | 55,000 | 57,000 | 55,000 | 56,000 | 56,000 | 56,000 | 56,000 | 14,000 | |||||||||||||||
stock-based compensation | 9,636,000 | 8,042,000 | 10,306,000 | 12,214,000 | 10,754,000 | 8,328,000 | 8,470,000 | 129,000 | 156,000 | 93,000 | 114,000 | 117,000 | 109,000 | 124,735 | 112,694 | 58,000 | 229,539 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash operating lease expense | 1,720,000 | 1,713,000 | 1,686,000 | 1,769,000 | 1,584,000 | 1,904,000 | 2,229,000 | 2,392,000 | 2,401,000 | 2,375,000 | 2,212,000 | 2,318,000 | 2,330,000 | 2,400,000 | 2,386,000 | 2,336,000 | 2,653,000 | 2,549,000 | 2,417,000 | 1,888,000 | 1,862,000 | -197,000 | 2,252,000 | 2,092,000 | 2,021,000 | 2,411,000 | ||||||||||||||||||||||||||||||||||||||||||||||
other adjustments | 402,000 | -326,000 | 343,000 | -377,000 | 37,000 | 37,000 | -18,000 | 216,000 | -57,000 | -1,543,000 | 1,696,000 | -31,000 | -174,000 | 476,000 | 1,126,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable | -8,182,000 | -4,207,000 | -2,368,000 | 1,065,000 | -668,000 | 888,000 | -4,848,000 | -6,301,000 | -9,052,000 | 1,412,000 | -7,215,000 | -6,583,000 | 870,000 | -7,717,000 | -718,000 | -480,000 | 1,334,000 | -7,166,000 | 1,320,000 | -2,766,000 | 3,921,000 | -3,146,000 | -15,953,000 | 12,220,000 | -5,722,000 | -3,082,000 | -1,041,000 | -7,383,000 | -5,795,000 | |||||||||||||||||||||||||||||||||||||||||||
inventories | -1,271,000 | -28,000 | 5,632,000 | -4,123,000 | -3,024,000 | -2,291,000 | -1,243,000 | -3,001,000 | 3,836,000 | -202,000 | 636,000 | -688,000 | -200,000 | -697,000 | -1,936,000 | 1,978,000 | -445,000 | -1,562,000 | -449,000 | 800,000 | 2,845,000 | -9,493,000 | 984,000 | -1,340,000 | -5,348,000 | -1,772,000 | -3,899,000 | 936,000 | -1,019,000 | 449,000 | -821,000 | 21,000 | ||||||||||||||||||||||||||||||||||||||||
prepaid and other assets | -1,395,000 | 3,205,000 | -514,000 | 1,969,000 | -3,105,000 | -5,625,000 | -1,522,000 | 2,292,000 | -1,976,000 | 1,985,000 | -2,551,000 | -1,427,000 | -1,187,000 | 2,445,000 | -1,403,000 | -158,000 | -2,044,000 | 9,890,000 | -7,115,000 | -3,887,000 | -794,000 | -5,561,000 | 1,093,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
operating lease liabilities | -1,299,000 | -1,233,000 | -795,000 | 903,000 | -1,090,000 | -1,712,000 | -979,000 | -1,876,000 | -1,432,000 | -1,752,000 | -2,577,000 | -1,572,000 | -1,722,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred income tax liabilities | -769,000 | -2,694,000 | 869,000 | -993,000 | -541,000 | -1,556,000 | -244,000 | -475,000 | -795,000 | -1,813,000 | -3,441,000 | -2,904,000 | -3,035,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued compensation | -7,004,000 | -4,098,000 | 2,773,000 | 8,617,000 | -22,957,000 | 10,279,000 | 1,285,000 | 16,271,000 | -18,552,000 | 5,567,000 | 1,908,000 | 12,795,000 | -7,250,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable and other liabilities | 718,000 | -5,823,000 | 6,575,000 | 1,143,000 | 5,037,000 | -4,847,000 | -138,000 | -2,481,000 | -4,610,000 | 4,101,000 | 43,000 | 1,037,000 | -1,078,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from operating activities | -8,137,000 | 1,343,000 | 8,884,000 | 20,330,000 | -25,327,000 | 9,800,000 | 9,246,000 | 13,892,000 | -25,915,000 | 17,784,000 | -5,497,000 | -1,548,000 | -12,692,000 | -3,685,000 | -16,272,000 | -16,996,000 | -29,040,000 | -19,776,000 | -7,767,000 | -1,390,000 | 2,210,000 | 5,985,000 | 526,000 | 1,882,000 | -6,933,000 | 3,359,000 | 18,634,000 | -4,721,000 | 6,097,000 | 15,453,000 | 8,381,000 | 6,640,000 | 14,312,000 | 5,759,000 | 7,436,000 | 6,528,000 | -1,686,000 | -241,000 | 9,623,000 | 5,036,000 | 7,059,000 | 2,121,000 | 2,375,000 | 2,684,000 | -787,000 | 986,000 | 3,166,000 | 4,273,000 | 1,025,000 | -505,000 | 2,199,000 | 1,863,000 | -1,330,000 | 1,081,000 | -1,065,000 | 1,239,000 | -116,000 | 490,000 | -1,544,000 | 361,000 | -925,000 | 76,000 | -1,564,000 | -454,517 | -513,322 | -201,039 | -331,539 | -181,654 | -521,601 | 194,638 | ||
capital expenditures | -5,000,000 | -7,871,000 | -8,314,000 | -6,323,000 | -4,500,000 | -11,599,000 | -10,799,000 | -13,078,000 | -5,585,000 | -7,057,000 | -4,274,000 | -7,494,000 | -9,927,000 | -4,534,000 | -7,844,000 | -10,294,000 | -8,219,000 | -11,987,000 | -14,977,000 | -21,347,000 | -15,831,000 | -11,505,000 | -7,857,000 | -5,026,000 | -4,708,000 | -6,076,000 | -7,316,000 | -3,441,000 | -3,196,000 | -3,219,000 | -2,148,000 | -4,277,000 | -4,666,000 | -3,523,000 | -2,303,000 | -4,857,000 | -3,007,000 | -2,208,000 | -1,903,000 | -2,424,000 | -1,001,000 | -533,000 | -502,000 | -338,000 | -842,000 | -1,053,000 | -753,000 | -1,083,000 | -883,000 | -525,000 | -878,000 | -369,000 | -239,000 | -760,000 | -277,000 | -559,000 | -213,000 | -54,000 | -71,000 | -103,000 | -313,000 | -386,000 | -114,000 | -531,558 | -292,736 | -133,560 | -5,886 | -370,218 | -170,764 | -25,115 | ||
free cash flows | -13,137,000 | -6,528,000 | 570,000 | 14,007,000 | -29,827,000 | -1,799,000 | -1,553,000 | 814,000 | -31,500,000 | 10,727,000 | -9,771,000 | -9,042,000 | -22,619,000 | -8,219,000 | -24,116,000 | -27,290,000 | -37,259,000 | -31,763,000 | -22,744,000 | -22,737,000 | -13,621,000 | -5,520,000 | -7,331,000 | -3,144,000 | -11,641,000 | -2,717,000 | 11,318,000 | -8,162,000 | 2,901,000 | 12,234,000 | 6,233,000 | 2,363,000 | 9,646,000 | 2,236,000 | 5,133,000 | 1,671,000 | -4,693,000 | -2,449,000 | 7,720,000 | 2,612,000 | 6,058,000 | 1,588,000 | 1,873,000 | 2,346,000 | -1,629,000 | -67,000 | 2,413,000 | 3,190,000 | 142,000 | -1,030,000 | 1,321,000 | 1,494,000 | -1,569,000 | 321,000 | -1,342,000 | 680,000 | -329,000 | 436,000 | -1,615,000 | 258,000 | -1,238,000 | -310,000 | -1,678,000 | -986,075 | -806,058 | -334,599 | -337,425 | -551,872 | -692,365 | 169,523 | ||
cash flows from investing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from maturities of marketable securities | 0 | 9,000,000 | 3,000,000 | 8,060,000 | 6,132,000 | 7,283,000 | 20,391,000 | 20,110,000 | 24,252,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of property and equipment | -5,000,000 | -7,871,000 | -8,314,000 | -6,323,000 | -4,500,000 | -11,599,000 | -10,799,000 | -13,078,000 | -5,585,000 | -7,057,000 | -4,274,000 | -7,494,000 | -9,927,000 | -4,534,000 | -7,844,000 | -10,294,000 | -8,219,000 | -11,987,000 | -14,977,000 | -21,347,000 | -15,831,000 | -11,505,000 | -7,857,000 | -5,026,000 | -4,708,000 | -6,076,000 | -7,316,000 | -3,441,000 | -3,196,000 | -3,219,000 | -2,148,000 | -4,277,000 | -4,666,000 | -3,523,000 | -2,303,000 | -4,857,000 | -3,007,000 | -2,208,000 | -1,903,000 | -2,424,000 | -1,001,000 | -533,000 | -502,000 | -338,000 | -842,000 | -1,053,000 | -753,000 | -1,083,000 | -883,000 | -525,000 | -878,000 | -369,000 | -239,000 | -352,000 | -1,226,000 | -760,000 | -277,000 | -559,000 | -213,000 | -54,000 | -71,000 | -103,000 | -313,000 | -386,000 | -114,000 | -531,558 | -292,736 | -133,560 | -5,886 | -370,218 | -170,764 | -25,115 |
net cash from investing activities | -5,000,000 | -6,305,000 | -277,000 | -9,314,000 | 3,560,000 | -5,467,000 | -3,516,000 | 7,313,000 | 14,525,000 | 17,195,000 | 20,821,000 | 14,949,000 | 23,742,000 | -1,063,000 | -4,198,000 | -6,274,000 | 12,052,000 | -9,583,000 | -14,686,000 | -453,410,000 | -154,688,000 | -28,854,000 | -70,716,000 | -18,163,000 | -41,708,000 | -6,076,000 | -7,316,000 | -3,042,000 | -3,196,000 | -128,596,000 | -2,148,000 | -4,277,000 | -4,666,000 | -3,523,000 | -2,303,000 | -4,857,000 | -3,007,000 | -1,173,000 | -1,903,000 | -2,424,000 | -1,001,000 | -73,473,000 | -502,000 | -338,000 | -842,000 | -1,054,000 | -6,582,000 | -1,083,000 | -883,000 | -525,000 | -878,000 | -369,000 | -239,000 | -736,000 | -1,314,000 | -559,000 | -213,000 | -54,000 | -71,000 | -103,000 | -313,000 | -386,000 | -114,000 | -531,558 | -292,736 | -133,560 | -5,886 | -370,218 | -170,764 | -25,115 | ||
cash flows from financing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock | -338,000 | 431,000 | 765,000 | -1,183,000 | 949,000 | 687,000 | 1,177,000 | 1,966,000 | 816,000 | 1,274,000 | 1,846,000 | 93,000 | 1,411,000 | 1,854,000 | 3,091,000 | 1,239,000 | 6,403,000 | 2,970,000 | 4,065,000 | 5,428,000 | 2,617,000 | 9,549,000 | 5,292,000 | 2,004,000 | 3,465,000 | 1,070,000 | 2,071,000 | 3,813,000 | 4,248,000 | 2,649,000 | 135,857,000 | 5,105,000 | 483,000 | |||||||||||||||||||||||||||||||||||||||
net cash from financing activities | -338,000 | 431,000 | 765,000 | -202,433,000 | 949,000 | 687,000 | 1,177,000 | 1,966,000 | 816,000 | 1,270,000 | 1,841,000 | 64,000 | 1,379,000 | 1,802,000 | 2,959,000 | 1,011,000 | 6,057,000 | 2,460,000 | -6,720,000 | 204,610,000 | 524,935,000 | 8,265,000 | 4,115,000 | 222,600,000 | 617,000 | -3,158,000 | 137,000 | 162,004,000 | 483,000 | 4,547,000 | 102,785,000 | -8,124,000 | -7,249,000 | -1,670,000 | -3,854,000 | -1,775,000 | 3,204,000 | -14,996,000 | -571,000 | -82,000 | -10,222,000 | 60,806,000 | -859,000 | -642,000 | -812,000 | -609,000 | 32,759,000 | -3,552,000 | 409,000 | 935,000 | -1,028,000 | -1,486,000 | 4,329,000 | 181,000 | 1,231,000 | -535,000 | 2,507,000 | -701,000 | 346,000 | -337,000 | 3,051,000 | -716,000 | 616,000 | 826,000 | 1,708,000 | -510,903 | 3,236,383 | 175,131 | 726,444 | 972,664 | 923,979 | -49,738 |
net change in cash and cash equivalents | -13,475,000 | -4,499,000 | 9,394,000 | -191,471,000 | -20,818,000 | 5,020,000 | 6,907,000 | 23,171,000 | -10,574,000 | 36,249,000 | 17,165,000 | 13,465,000 | 12,429,000 | -5,875,000 | 11,455,000 | 154,241,000 | 3,384,000 | 109,005,000 | -5,738,000 | 2,352,000 | 610,000 | 1,279,000 | -104,000 | -1,489,000 | -16,410,000 | 7,149,000 | 2,530,000 | -4,164,000 | ||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents, beginning of period | 159,618,000 | 0 | 0 | 367,012,000 | 0 | 0 | 342,488,000 | 0 | 0 | 263,180,000 | 0 | 0 | 9,811,000 | 0 | 0 | 12,821,000 | 0 | 0 | 33,689,000 | 0 | 0 | 4,834,000 | 0 | 0 | 1,868,000 | 0 | 0 | 2,628,000 | 0 | 0 | 1,097,000 | 0 | 0 | 1,631,000 | 0 | 0 | 468,171 | 210,573 | 210,573 | 210,573 | ||||||||||||||||||||||||||||||||
cash and cash equivalents, end of period | 146,143,000 | 9,394,000 | -191,471,000 | 346,194,000 | 6,907,000 | 23,171,000 | 331,914,000 | 17,165,000 | 13,465,000 | 275,609,000 | 11,455,000 | 154,241,000 | 13,195,000 | 109,005,000 | -5,738,000 | 15,173,000 | 1,279,000 | -104,000 | 11,036,000 | 7,149,000 | 2,530,000 | 19,256,000 | 1,014,000 | 1,704,000 | 31,248,000 | 29,343,000 | -362,000 | 5,385,000 | 293,000 | 8,000 | 4,628,000 | -528,000 | -190,000 | 2,756,000 | 17,000 | 99,000 | 2,533,000 | -622,000 | 516,000 | 1,661,000 | 2,430,325 | -159,468 | 857,190 | 631,365 | 442,187 | 330,358 | ||||||||||||||||||||||||||
amortization of convertible debt discount | 374,000 | 372,000 | 477,000 | 687,000 | 684,000 | 683,000 | 680,000 | 678,000 | 676,000 | 674,000 | 672,000 | 669,000 | 668,000 | 665,000 | 663,000 | 661,000 | 659,000 | 657,000 | 654,000 | 593,000 | 1,653,000 | 1,841,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of debt issuance costs | 46,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on disposal of assets | -112,000 | -42,000 | -208,000 | 108,000 | 246,000 | 17,000 | 21,000 | 47,000 | 248,000 | 156,000 | 172,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment charges | 626,000 | 7,086,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities, net: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable, accrued and other liabilities | 10,673,000 | 11,178,000 | -6,538,000 | 5,365,000 | 1,840,000 | -12,366,000 | 1,191,000 | -11,471,000 | 8,916,000 | -10,880,000 | 4,434,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of marketable securities | 0 | 0 | 0 | -6,756,000 | -23,632,000 | -17,641,000 | -40,165,000 | -16,167,000 | -15,830,000 | -18,192,000 | -24,993,000 | -137,776,000 | -19,705,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from assets held for sale, net of closing costs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
business acquisitions, net of cash acquired | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of convertible note | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of equity securities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of equipment financing obligations | -4,000 | -5,000 | -29,000 | -32,000 | -52,000 | -132,000 | -228,000 | -346,000 | -510,000 | -645,000 | -801,000 | -1,091,000 | -1,284,000 | -1,272,000 | -1,461,000 | -1,598,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of convertible debt | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, beginning of year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, end of year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of debt issue costs | 9,000 | 21,000 | 48,000 | 47,000 | 47,000 | 47,000 | 46,000 | 46,000 | 45,000 | 46,000 | 45,000 | 45,000 | 45,000 | 43,000 | 26,000 | 42,000 | 70,000 | 67,000 | 73,000 | 100,000 | 150,000 | 150,000 | 150,000 | 129,000 | 113,000 | 110,000 | 111,000 | 109,000 | 110,000 | 2,965,000 | 174,000 | 176,000 | 182,000 | 0 | 41,000 | 13,000 | 12,000 | 13,000 | 12,000 | 12,000 | 12,000 | 9,000 | 10,000 | 10,000 | 9,000 | 10,000 | 9,000 | 10,000 | 11,000 | 11,000 | 10,000 | 10,000 | 18,000 | 22,095 | 16,654 | 16,655 | 13,245 | 35,321 | 22,076 | 8,830 | ||||||||||||
other impairment charges | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of equity securities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
business acquisition, net of cash acquired | -463,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net change in cash and cash equivalents, including cash classified within current assets held for sale | 9,372,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: net change in cash classified within current assets held for sale | 22,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of assets | 117,000 | 0 | 188,000 | 145,000 | 923,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of assets held for sale | 0 | 0 | 0 | -2,048,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from assets held for sale | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash stock-based compensation | 7,774,000 | 6,990,000 | 7,180,000 | 5,705,000 | 4,758,000 | 4,663,000 | 4,280,000 | 3,626,000 | 12,103,000 | 10,062,000 | 5,237,000 | 4,506,000 | 2,653,000 | 2,676,000 | 2,715,000 | 2,635,000 | 2,186,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on investment in and loan receivable from non-consolidated affiliate | 0 | -17,750,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest on loan receivable from non-consolidated affiliate | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
write off of covid-19 pcr testing inventory and equipment | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other non-cash items | 1,159,000 | 598,000 | 242,000 | 548,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid lease asset | -353,000 | 295,000 | -3,907,000 | -823,000 | -10,087,000 | -4,058,000 | -2,768,000 | -3,316,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loan receivable from non-consolidated affiliate | 0 | 0 | 0 | -15,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of convertible debt, net of issuance costs | 0 | 0 | 0 | 334,410,000 | 0 | 90,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
premiums paid for capped call transactions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from equity offering, net of issuance costs | 218,290,000 | 0 | 5,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales and maturities of marketable securities | 22,443,000 | 40,425,000 | 27,103,000 | 21,287,000 | 32,087,000 | 36,438,000 | 18,234,000 | 18,483,000 | 12,334,000 | 13,919,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income | -22,687,000 | -36,852,000 | -41,759,000 | -20,347,000 | 15,417,000 | 6,296,000 | 2,143,000 | 1,991,000 | -2,424,000 | 353,000 | 2,023,000 | -380,000 | 644,000 | -5,100,000 | -43,000 | -654,000 | -6,223,000 | -68,000 | 413,000 | 155,000 | -1,473,000 | -125,000 | -176,000 | -761,000 | 1,047,000 | -291,000 | 274,000 | 102,000 | 857,000 | 900,000 | 273,000 | 3,000 | -113,000 | -976,000 | 551,000 | 603,000 | -893,000 | -978,000 | -750,000 | -755,306 | 8,060 | 33,178 | ||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on debt extinguishment | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on termination of cash flow hedge | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment in non-consolidated affiliate | 0 | -12,463,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of term loan | 0 | 0 | -96,290,000 | -1,250,000 | -2,500,000 | 0 | -94,782,000 | -1,968,000 | -1,313,000 | -54,587,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flow hedge termination | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted stock, beginning of year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest receivable on loan receivable from non-consolidated affiliate | 0 | -182,000 | -209,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
write-off of covid-19 pcr testing inventory and equipment | 0 | 0 | 6,061,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable, operating lease liabilities, deferred taxes, accrued and other liabilities | -3,095,000 | -7,195,000 | -9,902,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
premiums paid for capped call confirmations | 0 | 0 | -29,291,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net change in cash, cash equivalents and restricted cash | -17,511,000 | -22,259,000 | -10,931,000 | -29,173,000 | -250,190,000 | 372,457,000 | -66,075,000 | 206,319,000 | -48,024,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, beginning of period | 0 | 0 | 316,827,000 | 0 | 0 | 250,632,000 | 0 | 0 | 173,016,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, end of period | -17,511,000 | -22,259,000 | 305,896,000 | -29,173,000 | -250,190,000 | 623,089,000 | -66,075,000 | 206,319,000 | 124,992,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized loss on investment in non-consolidated affiliate | 5,024,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition working capital adjustment | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of revolving credit facility | 0 | 0 | 0 | 0 | -10,044,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from term loan | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments of debt issuance costs for term loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents, beginning of year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from equity offerings, net of issuance costs | -10,140,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
business acquisition | 0 | 0 | 0 | -37,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on investment in non-consolidated affiliate | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
advances on revolving credit facility | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
redemption of preferred stock | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
effects of foreign exchange rate changes on cash and cash equivalents | -33,000 | -13,000 | 23,000 | -45,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other current assets | -1,875,000 | -677,000 | -16,000 | 1,516,000 | -1,632,000 | -265,000 | -268,000 | -99,000 | -42,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of marketable securities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments of debt issuance costs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid assets | 270,000 | 779,000 | -630,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 86,254,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted cash, non-current | 38,738,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total cash, cash equivalents and restricted cash | 124,992,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosure of cash flow information: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest paid | 1,136,000 | 1,117,000 | 1,482,000 | 1,696,000 | 1,789,000 | 2,019,000 | 1,307,000 | 1,396,000 | 1,276,000 | 1,306,000 | 1,316,000 | 1,257,000 | 1,430,000 | 1,302,000 | 1,275,000 | 1,416,000 | 239,000 | 255,000 | 205,000 | 212,000 | 211,000 | 272,000 | 244,000 | 254,000 | 358,000 | 220,000 | 221,000 | 274,000 | 299,000 | 280,000 | 279,000 | 250,000 | 216,000 | 175,000 | 170,000 | 174,000 | 177,000 | 171,000 | 169,000 | 144,000 | 128,500 | 120,984 | 113,867 | 100,391 | 171,606 | 107,820 | 47,931 | |||||||||||||||||||||||||
income taxes paid | 2,000 | 227,000 | 8,000 | 42,000 | 7,000 | 12,000 | 170,000 | 97,000 | 5,000 | 62,000 | 6,000 | 15,000 | 207,000 | 5,000 | 0 | 15,000 | 5,000 | 7,000 | 0 | 11,000 | 159,000 | -2,000 | 2,000 | 0 | 17,000 | 2,000 | 7,000 | |||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosure of non-cash investing and financing information: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equipment acquired under financing obligations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
property and equipment included in accounts payable | 1,844,000 | -160,000 | -205,000 | 1,175,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of business | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash stock based compensation | 2,273,000 | 3,275,000 | 2,313,000 | 2,139,000 | 1,191,000 | 2,333,000 | 1,624,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets | -1,000 | 12,000 | 1,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition, net of cash acquired | -1,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of equipment and other loans | -1,720,000 | -1,837,000 | -1,847,000 | -1,797,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments of debt issue costs | -8,000 | -97,000 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from equity offering | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalent, beginning of year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents, end of year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition adjustment | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for operating lease liabilities | 1,015,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income taxes paid (refunded) | 45,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
working capital adjustment related to acquisition | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equipment acquired under loan obligations | 963,000 | 699,000 | 2,003,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash operating lease expenses | 1,077,000 | 1,141,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses | -250,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash fromoperating activities, net of business acquisition: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment/loss on sale of assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on extinguishment of debt | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock based compensation | 124,539 | 48,537 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities, net of business acquisition: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in accounts receivable, net of write-offs | 2,299,000 | 1,972,000 | -468,000 | -1,492,000 | -3,757,000 | -299,000 | -1,025,000 | -2,335,000 | -2,640,000 | -1,384,000 | -1,540,000 | -3,628,000 | -1,356,000 | -842,000 | -1,478,000 | -1,550,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in inventories | 90,000 | 68,000 | 617,000 | -41,000 | 513,000 | 283,000 | -225,000 | -267,000 | -613,000 | 298,000 | -233,000 | -330,000 | -93,000 | 214,000 | 47,000 | -380,000 | -215,000 | -109,000 | -107,000 | -16,000 | -168,000 | -24,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in other assets | 2,000 | 1,000 | 24,000 | -8,000 | 8,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in other current assets | -158,000 | 6,000 | 400,000 | -118,000 | 59,000 | -133,000 | 167,000 | -612,000 | -332,000 | 47,000 | -35,000 | 35,000 | 55,000 | -341,000 | -54,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in accounts payable and other liabilities | -6,910,000 | 5,163,000 | -2,059,000 | -738,000 | -5,374,000 | -205,000 | 636,000 | -664,000 | 2,731,000 | -237,000 | 844,000 | 673,000 | 770,000 | -1,419,000 | 794,000 | 170,000 | 179,000 | 300,000 | -666,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
(payments) advances from revolving credit facility | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of capital lease obligations | -1,203,000 | -1,079,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents | 1,014,000 | 1,704,000 | -2,441,000 | 29,343,000 | -362,000 | 551,000 | 293,000 | 8,000 | 2,760,000 | -528,000 | -190,000 | 128,000 | 17,000 | 99,000 | 1,436,000 | -622,000 | 516,000 | 30,000 | 2,430,325 | -159,468 | 389,019 | 420,792 | 231,614 | 119,785 | ||||||||||||||||||||||||||||||||||||||||||||||||
equipment acquired under capital lease/loan obligations | 0 | 3,836,000 | 378,000 | 3,355,000 | 2,488,000 | 683,000 | 659,000 | 1,898,000 | 1,150,000 | 2,322,000 | 2,412,000 | 173,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of property and equipment included in accounts payable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
fair value of common stock issued to fund acquisition | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
fair value of restricted stock issued to fund purchase of customer list | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of path logic | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(increase) in accounts receivable, net of write-offs | -1,929,000 | -3,327,000 | -6,651,000 | -4,276,000 | -9,989,000 | -9,001,000 | 580,000 | -6,195,000 | -3,809,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(increase) in prepaid expenses | 1,639,000 | -208,000 | -1,990,000 | 314,000 | 601,000 | -1,321,000 | -880,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(increase) in other current assets | -772,000 | 31,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in accounts payable, accrued and other liabilities | 385,000 | 2,260,000 | 6,782,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of capital lease obligations, loans | -1,760,000 | -1,620,000 | -1,394,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of customer list through issuance of restricted stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
advances from revolving credit facility | 0 | -2,501,000 | -9,000 | 5,006,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of term loan and revolving credit facility | -937,000 | -6,338,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of assets | -7,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments of equity issue costs | -85,000 | 0 | -112,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net | -143,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net (loss) to net cash provided by operating activities, net of business acquisition: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impact of tax valuation allowance | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
provision for bad debts | 5,623,000 | 4,999,000 | 4,244,000 | 3,783,000 | 3,673,000 | 2,749,000 | 2,771,000 | 2,663,000 | 393,000 | 230,000 | 930,000 | 884,000 | 831,000 | 579,000 | 646,000 | 741,000 | 619,000 | 699,000 | 896,000 | 839,000 | 827,000 | 631,000 | 515,000 | 594,000 | 508,000 | 580,000 | 626,000 | 540,000 | 795,823 | 424,266 | 426,737 | 507,741 | 1,095,387 | 815,011 | 425,453 | |||||||||||||||||||||||||||||||||||||
(increase) in inventories | -1,386,000 | -301,000 | -407,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition, net of cash acquired of 0, 0 and 890 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock for the exercise of options, warrants and espp shares, net of transaction expenses | 1,201,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
fair value of preferred stock issued to fund acquisition | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock based compensation – options, restricted stock and warrants | 2,760,000 | 1,922,000 | 1,130,000 | 1,687,000 | 1,634,000 | 703,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment to revolving credit facility | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of capital lease obligations/loans | -1,372,000 | -1,491,000 | -1,263,000 | -1,263,000 | -1,232,000 | -1,379,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment on term loan | -938,000 | -946,000 | -932,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the exercise of options, warrants and espp shares, net of transaction expenses | 1,042,000 | 1,105,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalent, beginning of period | 0 | 0 | 12,525,000 | 0 | 0 | 23,420,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deemed dividends on preferred stock | 912,000 | 928,000 | 894,000 | 1,840,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of preferred stock beneficial conversion feature | 1,739,000 | 1,711,000 | 1,672,000 | 3,727,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock for the exercise of options, warrants and espp shares | 505,000 | 220,000 | 270,000 | 109,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash provided by operating activities, net of business acquisition: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock based compensation – options and restricted stock | 1,301,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock based compensation – warrants | 271,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition, net of cash acquired of 0, 890 and 79 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
advances from (repayments to) revolving credit facility | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock for cash , net of transaction expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities, net of business acquisition: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in prepaid expenses | -401,000 | 91,000 | 7,000 | 389,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(decrease) in accounts payable and other liabilities | 2,180,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition, net of cash acquired of 890 and 79 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
bad debt expense | 546,000 | 701,000 | 602,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization of property and equipment | 1,722,000 | 1,663,000 | 1,586,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, net of write-offs | -972,000 | -348,000 | -1,610,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition, net of cash | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments on credit facility | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock for cash, net of transaction expense | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosure of cash flow information | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash investing and financing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equipment leased under capital lease obligations and equipment loans | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation – options and restricted stock | 471,000 | 342,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation – warrants | 148,000 | 59,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equipment leased under capital lease obligations | 875,000 | 2,525,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayments of capital lease obligations | -921,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(repayments to) advances from revolving credit facility | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted cash | 300,000 | 0 | 0 | 200,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock issued for intangible asset purchase | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation of property and equipment | 1,538,000 | 1,249,000 | 1,151,000 | 1,074,000 | 1,063,000 | 1,062,000 | 990,000 | 944,000 | 856,000 | 749,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation – options | 320,000 | 157,000 | 89,000 | 9,000 | 130,000 | 254,000 | 230,000 | 153,000 | 105,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation – warrants and restricted stock | 138,000 | 40,000 | -5,000 | -125,000 | 73,000 | 189,000 | 127,000 | 38,000 | 46,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
advances (payments) on credit facility | -1,990,000 | -458,000 | 1,642,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of capital leases and loans | -393,000 | -361,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock for the exercise of stock options and warrants | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock for cash, net of transaction expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equipment leased under capital leases | 1,503,000 | 1,628,000 | 1,693,000 | 1,433,000 | 414,000 | 1,021,000 | 381,000 | -63,000 | 705,000 | 966,000 | 1,174,000 | 1,587,000 | 732,000 | 382,000 | 141,000 | 255,000 | 316,000 | 357,000 | 746,000 | 713,290 | 378,271 | 507,086 | 178,837 | |||||||||||||||||||||||||||||||||||||||||||||||||
repayment of capital leases | -674,000 | -533,000 | -549,000 | -555,000 | -377,000 | -300,000 | -216,993 | -187,157 | -137,938 | -244,612 | -139,905 | -63,208 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock and warrants for cash, net of transaction expenses | 104,000 | 8,000 | 122,000 | 307,000 | 74,000 | 3,018,000 | 35,000 | 34,000 | 82,000 | 5,311,562 | -76,865 | 495,309 | 41,055 | 10,413 | 13,470 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
advances (repayments) on credit facility | 583,000 | -4,268,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayments of capital leases and loans | -772,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock and warrants for cash, net of transaction costs | 598,000 | 9,167,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock based compensation – options | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock based compensation – warrants and restricted stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
advances (repayments) from/to revolving credit facility | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock and warrants for cash , net of transaction expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of intangible assets | -24,000 | 24,000 | -1,037,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash intangible asset purchase | 0 | 1,945,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayments of capital leases | -570,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash (used) in operating activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash (used) in investing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
advances on credit facility | 2,788,000 | 653,000 | -33,000 | 410,000 | 943,000 | 504,000 | 1,901,000 | -1,858,186 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of capital lease on owned assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
automobiles purchased under a car loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net (loss) to net cash from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in deposits | -35,000 | 17,000 | -19,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in accounts payable, accrued expenses and other liabilities | -316,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from capital lease obligations | -1,000 | 122,000 | 25,000 | 0 | 0 | 96,890 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in restricted cash | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock, net of transaction costs | 86,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from provided by operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash consulting expenses | 33,000 | 36,000 | 41,000 | 108,000 | 19,000 | 18,696 | 18,696 | 10,622 | 19,724 | 99,813 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock issued for the purchase of assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(increase) decrease in accounts receivable, net of write-offs | -825,000 | -518,000 | -1,401,000 | -642,834 | -1,549,476 | -1,239,702 | -1,220,083 | -126,607 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(increase) decrease in inventories | 39,000 | -225,000 | 20,000 | -20,882 | -86,271 | -39,857 | -59,508 | 58,764 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(increase) decrease in prepaid expenses | 1,000 | -148,000 | 122,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(increase) decrease in deposits | -15,492 | -8,282 | -14,512 | 5,009 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase (decrease) in accounts payable and other liabilities | -148,000 | 663,000 | -656,000 | -207,774 | 471,539 | -79,447 | -38,205 | -122,462 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equipment purchased and included in accounts payable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equipment purchased and payables settled with issuance of restricted common stock | 0 | 0 | 186,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on investments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other non-cash expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(increase) decrease in other current assets | -368,117 | -35,402 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase (decrease) in legal contingency | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in pre-paid expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equipment purchased and included in accounts payable at september 30 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(increase) decrease in pre-paid expenses | -154,768 | -27,996 | -405,841 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equipment purchased and included in accounts payable at june 30 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
advances / (repayments) on credit facility | 272,183 | 1,176,221 | 1,053,471 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equipment purchased and included in accounts payable at march 31 | 46,250 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of credit facility warrants and debt issue costs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment in other assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
advances (repayments) from/to affiliates | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
notes payable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of lease cap costs | 4,080 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of relocation costs | 8,862 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of credit facility warrants | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of convertible debenture | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
advances / (repayments) to affiliates | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of notes payable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equipment leased under capital leases, including 140,000 in accrued expenses at december 31, 2007 | 538,761 | 234,833 | 162,043 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equipment purchased and included in accounts payable at september 30, 2008 | 126,227 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non cash consulting expenses | 67,042 | 34,271 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equipment purchased and included in accounts payable at june 30, 2008 | 165,653 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase (decrease) in deposits | 12,201 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
advances from/(repayments to) affiliates | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equipment purchased and included in accounts payable at march 31, 2008 | 33,713 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from bad debts | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in accounts receivable, net of write-offs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in inventories | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in other current assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in deposits | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash provided by/(used in) operating activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash provided by/(used in) financing activities |